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ABSTRACT 
One of the largest challenges in genomics studies is determining the relationship 
between genotype and phenotype and then applying this knowledge to design principles. 
Metabolic engineering of bacteria can introduce targeted genomic interventions to well-
characterized genes for the purpose of modifying cellular metabolism, but in some cases, 
even for the model organism Escherichia coli, alternative strategies are required to 
achieve a desired phenotype. Metabolic evolution involves applying selective pressure to 
a population, and over time advantageous mutations will arise that improve organism 
fitness. To understand what mutations occurred during these experiments and how they 
affect phenotype, whole genome sequencing is required, followed by mutation analysis 
and strain characterization. 
Genome sequencing generates a large amount of data for researchers to examine 
and traditionally mutation analysis focuses only on gene variations. Supporting mutation 
analysis with computational tools and using a systems-level approach that utilizes public 
databases describing gene regulation and cellular metabolism improves upon existing 
analysis techniques and advances our understanding of how genotype relates to 
phenotype. 
Using our mutation analysis software, E. coli Variant Analysis (EVA), we 
examine antibiotic resistance, benzoate tolerance, and octanoic acid tolerance in E. coli. 
Our analysis pipeline includes a defined set of rules for mutation categorization. 
Prioritization of mutations supports efforts to reverse-engineer evolved strains and focus 
on the variants most likely to be damaging or relevant to phenotype. From mutation 
analysis results, we construct biological networks for visualization of mutations and 
x 
possible downstream effects. This allows for improved mutation interpretation and 
identification of possible mutation interactions. Furthermore, we integrate RNA-seq data 
into our analysis to investigate the effects of variant regulators on the transcriptome. In 
contrast to existing methods which focus on mutated genes, we incorporate annotations 
for binding sites and other regulatory features on the genome for the most complete 
interpretation based on the available genome and gene regulatory models. 
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CHAPTER 1.    INTRODUCTION 
Metabolic Evolution in Bacteria 
Microbial metabolic engineering is an essential tool for generating organisms capable 
of specialized chemical production. The Center for Biorenewable Chemicals aims to use a 
combination of biocatalysis and chemical catalysis methods in order to establish a sustainable 
system to produce bio-based chemicals using a model organism such as Escherichia coli and 
Saccharomyces cerevisiae. The biocatalysis component involves engineering microbial 
strains by adding extrinsic functionalities, such as introducing new enzymes, and redirecting 
target metabolic pathways. In such a way, it is possible to develop a biological system that 
uses carbohydrate feedstock as input for the production of target chemicals.  
Rational design introduces genome modifications in a purposeful manner based on 
knowledge of gene models and metabolic pathways. Gene knockouts and gene 
overexpression can modify metabolic pathways to direct carbon flow toward a desired 
process. Incorporation of novel enzymes can add new synthesis pathways to an organism for 
production of desired chemicals. However, target chemicals at high titers can cause toxicity 
which must be overcome for economically feasible production. 
Without fully characterizing the toxicity effect, metabolic evolution can be employed 
to generate a strain that exhibits improved tolerance. Metabolic evolution is a powerful 
method that requires minimal knowledge of the platform organism or underlying biological 
mechanisms to obtain a strain with a desired phenotype. It is considered a black box 
technique because scientists do not control or observe genetic changes as they occur. In a 
metabolic evolution experiment, variant strains with advantageous phenotypes emerge under 
strong selective pressure and displace the parent strain in a population. Improved fitness is 
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attributed to one or more mutations acquired during the experiment. Metabolic evolution may 
be repeated along with additional genomic interventions to obtain a desired phenotype. 
Reverse engineering of the evolved strain is required to elucidate which mutations are 
relevant to fitness and by what mechanisms. Reverse engineering involves a comparative 
analysis of the genomes of the parental strain and evolved strain to identify mutations and 
characterization of each mutation as well as their combined effects. In addition to 
comparative genomic analysis, additional omics studies may be performed to characterize 
evolved strain(s) and identify factors that contribute to improved fitness. Reverse engineering 
also requires reconstructing verified mutations in the parent strain and repairing mutations in 
evolved strains for comparative analyses. An overview of this design strategy for strain 
design is provided in Figure 1.1. Bioinformatics can aid in reverse engineering by predicting 
which variations may be damaging to genomic features and how mutated elements may 
affect other biological features through regulation and cellular metabolism. Understanding 
how sequence variations can affect genes, binding sites, and other genomic sequences is 
critical to characterizing an evolved strain. In some cases, biological elements with 
regulatory features are mutated, which have the potential to lead to large scale changes in 
gene expression. Gene regulatory network data can help identify downstream elements which 
could be indirectly affected such a mutation. Integrating this information with pathway data 
can highlight metabolic activities that may be altered and have relevance to phenotype. 
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Figure 1.1 Microbial engineering to achieve a desired phenotype. 
Both metabolic evolution and rational engineering strategies may be used in an iterative 
manner to achieve a desired phenotype. Metabolic evolution requires reverse engineering of 
evolved strain(s) to identify key mutations and understand their relevance to phenotype. 
 
Octanoic acid toxicity in E. coli 
Carboxylic acid is a testbed in E. coli from which CBiRC envisions generating 
multiple biorenewable chemical products. Fatty acids are useful in industrial applications 
including surfactants and lubricants (Makkar & Cameotra, 2002) and are an attractive target 
chemical due to the ability to break the elongation cycle at varying chain lengths by 
introducing foreign acyl-ACP thioesterases with different specificities (X. Zhang, Li, 
Agrawal, & San, 2011). However, at high concentrations, fatty acids become toxic to the E. 
coli, limiting titers, yields, and productivity. Specifically, fatty acid toxicity in E. coli has 
been shown to be related to membrane damage (Desbois & Smith, 2010; R. M. Lennen et al., 
2011). Toxicity effects on the membrane were also investigated in an octanoic acid (C8) 
challenge by characterizing the effect on the membrane (L. A. Royce, P. Liu, M. J. Stebbins, 
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B. C. Hanson, & L. R. Jarboe, 2013), confirming that short chain fatty acids damage cell 
membrane by increasing membrane fluidity and porosity. 
To further characterize the mechanisms of fatty acid toxicity, we performed 
transcriptome analysis of E. coli during exogenous challenge of octanoic acid (C8) (Royce et 
al., 2014). In the experiment, E. coli K-12 MG1655 was grown to mid-log phase in MOPS 
minimal media with and without 10 mM C8 at initial pH of 7.0. RNA was hybridized to 
AffyMetrix GeneChip E. coli Genome 2.0 Arrays for three biological replicates of each 
condition and analyzed at the DNA facility of Iowa State University. I performed background 
adjustment, normalization, and summarization calculations in MATLAB using GCRNA 
(Irizarry, Wu, & Jaffee, 2006; Z. Wu, Irizarry, Gentleman, Martinez-Murillo, & Spencer, 
2004). Many genes with increased expression in response to the C8 challenge were related to 
acid response, response to and regulation of pH, and biofilm formation. Genes with 
decreased expression were related to reduced motility, chemotaxis, and flagellum assembly. 
In addition, we identified perturbed genes associated with membrane function and integrity: 
bhsA, cpxP, cfa, and ompF. I also performed Network Component Analysis (NCA) (Fu, 
Jarboe, & Dickerson, 2011; Liao et al., 2003) to predicted altered transcription factor activity 
based on changes in transcript abundance of regulated genes. Notably, the transcription factor 
GadE (glutamate-dependent acid resistance system) was predicted to have altered activity, 
attributed to increased expression in acid resistance genes hdeABD and gadABCE in response 
to C8. Due to the significant increase in activity of the GadE regulon, glutamate 
supplementation was tested as a method to increase tolerance C8 but did not prove effective. 
We hypothesize that membrane damage impairs the glutamate-dependent acid resistance 
system during C8 challenge. 
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Octanoic acid-tolerant E. coli 
To overcome toxicity limitations, a more robust strain was engineered using a 
combination of rational design and metabolic evolution methods. The parent strain for the 
metabolic evolution experiment was ML115, which had been engineered with three deletions 
(fadD, ack-pta, and poxB) to inactivate the fatty acid beta-oxidation pathway to halt fatty acid 
degradation and two acetate pathways to redirect flux to increase the acetyl-CoA pool (M. Li, 
Zhang, Agrawal, & San, 2012). Microbial metabolic evolution was performed by 15 
sequential transfers with increasing C8 concentration from 10 mM to 30 mM over 714 hours. 
At the end of the experiment, evolved strains LAR1 and LAR2 were isolated for genome 
sequencing along with the parent strain (L. A. Royce et al., 2015). 
Genomic DNA of evolved strains LAR1, LAR2, and the parent strain, ML115, was 
isolated and sequenced using Illumina whole genome sequencing. I aligned short reads to the 
MG1655 reference genome and predicted mutations using methods outlined in (L. Royce, E. 
Boggess, T. Jin, J. Dickerson, & L. Jarboe, 2013) and found in Appendix A. Mutations 
predicted in both the ancestral and evolved strains were not considered for further analysis. A 
key mutation that was found in both evolved strains occurred in rpoC, which encodes the β’ 
subunit of RNA polymerase. A point mutation from A to C at position 1256 in rpoC results 
in an amino acid change of H419P. Two other mutations were predicted in basR (LAR1) and 
basS (LAR2) genes. In basR, a point mutation of G to T at position 82 results in an amino 
acid change of D28Y. In basS, a 27 base pair (bp) deletion results in the deletion of nine 
amino acids in the protein BasS. 
Genomic Mutations 
Spontaneous mutations may result from errors in DNA replication, DNA lesions, and 
transposable elements. Errors in DNA replication can arise when mis-paired nucleotides 
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result in a base substitution and strand slips at repeated sequences. Naturally occurring 
damage to DNA can cause spontaneous lesions that can lead to mutations. Depurination, the 
spontaneous loss of the glycosidic bond between a base and deoxyribose can lead to a 
substitution or loss of a nucleotide pair. Deamination of cytosine to uracil results in a base 
substitution. Oxidative damage can also cause DNA lesions leading to mutagenesis. In rare 
cases, the DNA molecule itself may break and in the act of non-homologous end joining 
nucleotides may be added or removed to repair the molecule (Moore & Haber, 1996). 
Finally, transposable elements, or “jumping genes,” consist of DNA sequences that are 
capable of moving and inserting into the genome at new positions. In a laboratory setting, 
increased mutation rates can be achieved with the use of chemicals that destabilize DNA 
molecules and by irradiation (e.g., ultraviolet light) (Lee, Feist, Barrett, & Palsson, 2011). 
Genomic mutations in bacterial systems can be categorized by their impact on DNA 
sequence. The following mutation types apply to bacterial systems in evolution studies: 
substitution, deletion, insertion, indel, amplification, and translocation. Substitution mutation 
describe replacing bases with an alternative sequence. A single nucleotide polymorphism 
(SNP) describes the substitution of a single base ((A)denine, (C)ytosine, (G)uanine, 
(T)hymine) for another. Deletions and insertions describe the excision or addition of 
nucleotides in the genome, respectively. In some cases, a more complex mutation may occur 
that results in a deletion and insertion of unequal lengths, which is known as an indel 
(insertion-deletion of DNA). Amplifications describe the replication of a DNA sequence and 
translocations refer to a DNA sequence that is relocated to a different position on the 
genome. 
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 Furthermore, mutations can be described by their change to protein-coding genes. 
Silent mutations describe an altered DNA sequence, but no change in the amino acid 
sequence. Missense mutations describe the substitution of an amino acid for another. A 
special case is the substitution of an amino acid for a premature stop codon, which is known 
as a nonsense mutation. A mutation that results in the loss of a stop codon is known as a 
nonstop or read-through mutation and transcription may continue until the next stop codon is 
encountered. In some cases, stop and start codons are preserved, but a DNA mutation results 
in an alternate stop/start codon that can alter translation initiation rates (Hecht et al., 2017) or 
require alternative release factors (Korkmaz, Holm, Wiens, & Sanyal, 2014). In-frame 
insertions, deletions, an indels that result in the insertion or deletion of amino acids and out-
of-frame mutations cause frameshifts that modify downstream codons and may result in loss 
of function. 
Genotype-Phenotype Relationship 
As the price of DNA sequencing continues to fall, more genomic data will continue to 
be generated for metabolic evolution and comparative studies. However, using the genetic 
sequence of an organism to predict its phenotype is an open biological problem. A similar 
ambition is to measure features of organism phenotype through molecular and cellular 
experiments and trace these characteristics back to features on the genome. An understanding 
the relationship between the genome and phenotypic traits aids both goals. Even for model 
organisms, discerning genotype-phenotype relationships remains a challenge as our 
knowledge of biological systems is incomplete and existing models are composed of 
entangled networks of regulatory activities such that altering one element may affect many 
other features. 
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Mutations in coding regions can alter transcript abundance, product abundance, and 
product function. Some genes encode transcription factors which regulate transcription of 
other genes. A variant transcription factor may show altered activity or binding site 
specificity, resulting in altered expression of regulated genes. In addition to genes, mutations 
in regulatory sites can contribute to the phenotype of evolved strains. Regulation of gene 
expression is a critical response mechanism to environmental stimuli and integral to 
controlling cellular behavior. Altering parameters such binding site affinity, transcription 
factor abundance, and regulatory elements functioning as secondary structures can also affect 
transcription and translation regulation. Gene products either directly (via genomic 
mutations) or indirectly (via regulation) changed by mutations can affect cellular structure or 
metabolism resulting in an observed phenotypic trait. Additionally, multiple mutations and 
may be additive, synergistic, or antagonistic in nature (Elena & Lenski, 1997; Szathmáry, 
1993).  
Goal of this work 
After a metabolic engineering experiment, a bottleneck occurs when mapping genetic 
modifications to phenotype. Analysis of strains obtained through metabolic evolution 
traditionally involves manual annotation of mutations in coding regions and evaluation of 
their individual contribution to fitness through functional or comparative studies. Typically, 
analysis does not consider extragenic variations (mutations outside of coding regions). The 
massive amount of sequence variation data generated in evolution experiments necessitates 
computational tools that can assess mutation implications. 
The goal of this project is to construct a framework to systematically analyze 
mutations and provide interpretations for both direct impact of mutations and potential 
downstream effects that occur through regulation. In doing so, we aim to support efforts to 
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reverse engineer adapted strains generated from metabolic engineering experiments and 
reduce the amount of time to a secondary round of metabolic engineering. 
To achieve this goal, genes, products, regulatory elements, metabolic pathway 
information, and relationships of these entities are included in the mutation analysis pipeline. 
Data is queried from publicly available databases RegulonDB (S. Gama-Castro et al., 2016) 
and EcoCyc (I. M. Keseler et al., 2017). 
 
Figure 1.2  Overview of EVA software design. 
EVA accepts text files that contain positional and sequence information about genomic 
mutations as input. Annotations for each mutation are obtained by querying publicly 
available E. coli databases. Depending on the type of mutation, various strategies can be 
employed for additional analysis, some of which use published protein sequences obtained 
from NCBI. Gene regulatory and metabolic data are retrieved from publicly available 
databases and used to construct biological networks that aid in visualizing mutations, their 
effects, and potential interactions. A text file containing annotations, reference and alternate 
feature sequences, and other analysis results is also generated as part of EVA’s output. 
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Translating between DNA, RNA, and amino acid molecules and defining a set of rules for 
types of variations and regulatory activities aid interpretations. Additionally, mutations are 
examined for their effect on molecular structures and binding affinities to predict if they have 
a significant impact to the organism. The proposed methods benefit the research community 
by broadening the study of mutations and mechanisms of adaptation. Additionally, 
automating portions of comparative genomic analysis reduces the lifecycle of adaptive 
evolution studies. 
Thesis Organization 
The following chapters are a collection of research papers and book chapters that are 
either published, under review, or intended for submission for publication when complete. 
They are organized as follows: Chapters 2-4 are research papers presented on the topic of 
mutation analysis for evolved strains in metabolic engineering experiments and elucidating 
genotype-phenotype relationships. Chapter 5 is a general discussion on the significance and 
impact of studies presented in Chapters 2-4. Appendix A is a methods chapter on reverse 
engineering of evolved strains. Appendix B is a user manual for our mutation analysis 
software. Appendix C contains supplementary material. 
Chapter 2: Mutation Analysis for Metabolic Experiments in Escherichia coli 
This research paper describes E. coli Variant Analysis (EVA) software for mutation 
analysis in E. coli. Methods for annotating and interpreting mutations as well as integration 
with gene regulatory and metabolic networks are presented to investigate mutation effects 
and aid in elucidating their genotype-phenotype relationship. Additionally, algorithms for 
network reduction can highlight potential mutation-mutation interactions. 
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Chapter 3: Genome-level Reverse Engineering of Escherichia coli Evolved for Increased 
Short-Chain Fatty Acid Tolerance and Production 
Chapter 3 is a research paper that discusses metabolic engineering as a method for 
increasing tolerance and production of octanoic acid and genomic analysis of evolved E. coli 
strains. Assembly and analysis of short read sequence data is an integral part of this work. 
Comparative analysis of evolved and ancestral genomes is required for reverse engineering. 
Mutation analysis and interpretation identifies potentially damaging variants in the evolved 
strain, including a global regulator and transcription factor which may alter expression of 
many regulated genes. 
Chapter 4: Transcriptomic Analysis of Escherichia coli Evolved for Increased Short-Chain 
Fatty Acid Tolerance and Production 
Chapter 4 is a research paper extends previous work to reverse engineer E. coli 
evolved for octanoic acid tolerance with the addition of RNA-seq experiments. 
Transcriptomic analysis was performed for an evolved strain (LAR1) and ancestral strain 
(ML115) in both control and fatty acid production conditions at three time points. 
Normalization and differential expression analysis led to the identification of genes that were 
perturbed for all strain contrasts. This list of genes was then annotated with associated sigma 
factors and presence in the BasR. Genes with significant fold changes were submitted as 
candidates for further investigation into the effect of previously identified mutations in the 
global regulator, RpoC, and transcription factor, BasR. The use of EVA software in 
combination with transcriptomic data was a key component in predicting the effects of 
previously identified genomic mutations in transcription regulators. EVA was also used to 
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identify relationships among differentially expressed genes and highlight metabolic pathways 
in which they participate. 
Chapter 5: Conclusions and future work 
The final chapter summarizes important findings and discusses the significance of the 
work presented in chapters 2-4. The future work describes recommendations for extending 
and improving upon the work presented in this dissertation. 
Appendix A: Identification of Mutations in Evolved Bacterial Genomes 
Reverse engineering of microbial strains evolved in metabolic evolution experiments 
is necessary to understand the mechanisms that result in a desired phenotype. This book 
chapter details methods for short read analysis of genomic data and mutation identification. 
Appendix B: E. coli Variant Analysis (EVA) User Guide 
This section is a user guide for EVA software. Various software options and usage 
are described in detail.  
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Abstract 
Background 
Metabolic evolution, a tool used in strain engineering, involves applying selective 
pressure to induce advantageous mutations to a strain for manipulating characteristics such as 
tolerance, product yield, and growth properties. This method does not reveal which acquired 
mutations led to improved fitness, by what mechanism, or how mutated genomic features 
interact to produce a phenotype.  
 
Results 
This work establishes a pipeline for mutation analysis in Escherichia coli called E. 
coli Variant Analysis (EVA) that integrates public databases and multiple sequence analysis 
tools. EVA annotates mutations, applies analysis strategies to predict effects of variations, 
and constructs a biological network of mutated genomic features and downstream gene 
regulatory and metabolic pathway features. Biological networks produced by EVA aid in 
reverse engineering evolved strains. When applied to data from E. coli evolution 
experiments, EVA annotates mutations in non-coding regions that traditional analyses 
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overlook. Networks generated by EVA visualize regulons downstream of mutated features, 
mutation interactions, and mechanisms related to enhanced fitness. 
 
Conclusion 
EVA advances mutation interpretation by annotating regulatory features and 
incorporating gene regulatory, signaling pathway, and metabolic pathway data downstream 
of mutated features. EVA generates biological networks comprised of these features and their 
interactions to support reverse engineering of evolved strains. Software automation reduces 
the burden of annotation, interpretation, and prioritization of results, thereby decreasing the 
time to follow-up experimentation and further rounds of metabolic evolution. 
 
Background 
Microbial metabolic engineering can develop specialized strains that exhibit desired 
phenotypes. For well-characterized organisms, a rational design approach may be used for 
strain development (Jang et al., 2012). Rational design entails performing targeted genome 
modifications based on literature evidence, metabolic pathway knowledge, and 
computational predictions intended to alter enzyme abundance and/or function. When 
genome changes that enable the desired phenotype are unknown, researchers can perform a 
metabolic evolution. Under selective pressure, variants with advantageous mutations displace 
the parent strain in a population. Reverse engineering of evolved strains identifies beneficial 
genetic variations (Jin, Chen, & Jarboe). Metabolic evolution is often considered a black box 
technique because scientists do not control or observe genetic changes as they occur. 
As next-generation sequencing methods become more accessible and affordable, 
comparing the entire genomes of the parent strain and one or more evolved derivatives is 
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becoming common in evolutionary experiments (Barrick et al.; Haft et al.; Harden et al.; 
Herring et al.; LaCroix et al.). In these experiments, researchers align short-read data to the 
parent genome or a published wild-type ancestral genome and predict genetic variations 
between the reference and aligned strains with SNP-calling algorithms. Improved fitness in 
an evolved strain is attributed to genetic variations not present in the parent strain. 
Determining which mutations are random and which contribute to the evolved phenotype 
remains a reverse engineering challenge that requires a considerable amount of further 
research and experimentation. 
Traditionally, researchers inspect genomic variations in coding regions to determine 
if they disrupt gene transcription or protein function and search the literature for relevance to 
the observed phenotype (Byrne et al.; Utrilla et al.). While this can reveal important changes 
such as loss of function, it ignores mutations in non-coding regions responsible for regulatory 
activities. In other studies, researchers examine every predicted mutation, but this assumes all 
have equal importance and requires researchers to construct numerous variant strains to carry 
out necessary follow-up studies (Atsumi et al.). Parallel evolution experiments for multiple 
populations can identify commonalities in independently acquired mutations (Sandberg et 
al.). A more complex experimental design, VERT (Visualizing Evolution in Real-Time), 
involves collecting intermediate samples at various time points during the evolution 
experiment for populations in competition (Reyes, Winkler, & Kao, 2012). The VERT 
method provides insight into the order of acquired mutations and their relation to organism 
fitness. Regardless of experimental design, mutation interpretation remains a challenge. 
Methods to predict if amino acid sequence variants are tolerated or damaging include 
SDM (Site Directed Mutator) (Worth, Preissner, & Blundell), SIFT (Sorting Intolerant From 
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Tolerant) (Ng & Henikoff), and Provean (Protein Variance Effect Analyzer) (Choi, Sims, 
Murphy, Miller, & Chan). Each algorithm uses residue conservation statistics and amino acid 
properties to predict the likelihood of observing an amino acid substitution. These 
computational methods classify amino acid sequence variations into two general cases: 
tolerated and damaging. Tolerated variations are predicted not to affect protein function and 
damaging variations are predicted to impair protein function. Computational methods 
capable of predicting the introduction of novel functions due to a change in the amino acid 
sequence do not currently exist. 
The SDM algorithm relies upon amino acid substitution frequencies for families of 
homologous proteins with available structures and requires a Protein Data Bank (PDB) as 
input. SDM predicts disruptive mutations based on a stability score that describes the change 
in free energy between the wild-type and predicted variant protein structures and 
conservation of structural features. SDM offers a unique mutation analysis, however many 
proteins lack a PDB structure and proteins with more than one structure require researchers 
to choose which is most relevant to their experimental conditions, a constraint that is not 
readily automated. 
SIFT predicts the impact of missense mutations based on residue conservation 
calculated from BLAST multiple sequence alignments of homologous sequences and amino 
acid properties. The software accepts amino acid variations and their relative positions in a 
protein but does not support nucleotide variations in the genome as input. SIFT assumes that 
variants which occur naturally in highly similar sequences are less likely to disrupt a protein 
than variants that are rarely or not at all observed. SIFT may accept National Center for 
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Biotechnology Information (NCBI) protein IDs or an amino acid sequence in FASTA format 
as input. 
Provean is similar to SIFT, but employs the added step of clustering BLAST results 
and uses the BLOSUM62 (Henikoff & Henikoff) matrix for scoring amino acid substitutions 
rather than constructing a PSSM matrix based on BLAST results. Multiple sequence 
alignments are performed between the query amino acid sequence and clusters of related 
sequences and alignment scores are averaged. An amino acid variation is predicted to be 
damaging if the value is below a threshold (authors recommend a cutoff of ≤ -2.5 based on 
testing performed with the UniProt human dataset). Like SIFT, Provean is primarily intended 
for human studies but can be used for other organisms by submitting the wild-type amino 
acid sequence and a description of the variation. The description format follows Human 
Genome Variant Society (HGVS) format (J. T. den Dunnen & Antonarakis; Johan T. den 
Dunnen et al.). 
In addition to genes, mutations in regulatory sites can contribute to the phenotype of 
evolved strains. Regulation of gene expression is a critical response mechanism to 
environmental stimuli and integral to controlling cellular behavior. Tuning parameters such 
as RNA polymerase (RNAP) binding affinity, transcription factor abundance, transcription 
factor binding site (TFBS) affinity, and ribosome binding site (RBS) affinity can control 
RNA and protein abundance. One of the most extensively studied regulatory sites is the σ70 
promoter (Finn; Malhotra, Severinova, & Darst). It has been shown that point mutations in 
the consensus sequence can result in a broad range of gene expression control (Bakke et al.). 
For promoters and other binding sites, high-throughput studies on a large number of 
sequence variations to determine affinity and specificity (Stormo & Zhao). Changes to non-
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coding RNAs and regulatory elements functioning as secondary structures can also affect 
transcription and translation (Yu, Bing, & Zhenhua) and several metrics exist to describe 
conformational differences between wild-type and variant sequences (Avihoo & Barash, 
2006; Kiryu & Asai; Sabarinathan et al.).  
The proposed EVA workflow includes the following components: annotation, 
analysis, prioritization, and network construction as shown in Figure 2.1. Our method 
expands upon traditional mutation analysis by investigating changes to non-coding regulatory 
elements. While regulators correspond to a small percentage of total nucleotides, they occur 
throughout the entire genome and perform functions critical to transcription and translation. 
EVA prioritizes mutations based on their predicted effect on properties such as transcription 
and translation completion, structural stability, and binding site affinity. Based on the type of 
mutation and supporting information from sequence and structure analysis, EVA assigns 
annotated mutations a priority to aid researchers in interpretation and planning follow-up 
experimentation. A high priority indicates the mutation is predicted to be damaging to a gene 
or destroy a regulator function, a low priority indicates the mutation is predicted to be 
tolerated by the feature, and an unassigned priority denotes an undetermined effect. Finally, 
EVA identifies features indirectly affected by mutations in genes or regulators (e.g., a 
mutated promoter indirectly affects genes in its transcription unit) from the E. coli gene 
regulatory network. The E. coli metabolic network offers associated reaction and pathway 
data and insight into the phenotypic impact of mutations.  
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Figure 2.1  EVA pipeline 
Mutations are imported and are annotated with corresponding genomic features that include 
coding regions, structures, or binding sites. Each annotation is processed as either DNA or 
RNA and the reference (wild-type) sequence is compared to the alternate sequence to classify 
the mutation type. Mutations are classified based on if they are predicted to be damaging to 
the genomic feature. Nodes corresponding to genomic features in annotations are used as 
seed nodes to build a biological network based on gene regulatory and metabolic networks 
that illustrate downstream effects of genomic mutations.  
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Methods 
Mutation Annotation 
EVA compiles relevant genomic feature data (e.g., feature type, name, strand, 
position, and sequence) and determines the span for each annotation. The mutation span 
describes the mutation and genomic feature intersection on the genome. These cases include 
when the mutation is internal to the genomic feature, the mutation spans the left or right end 
of the genomic feature, the mutation coincides exactly with the genomic feature, or the 
mutation encompasses the genomic feature and surrounding DNA. Pairs of mutations and 
genomic features together form annotations. 
EVA accepts Variant Call Format (VCF version 4.3) files (.vcf), Breseq Genome Diff 
output files (.gd) or a comma-delimited text file (.csv or .txt) as input. CSV files must have 
one mutation per line, given as the genomic position, reference (wild-type) DNA sequence, 
and alternate DNA sequence. Users may submit input files designated as parent (i.e., 
ancestral) strains or derivative (i.e., evolved) strains. EVA requires at least one derivative 
strain. 
EVA implements an interface to RegulonDB (Gama-Castro et al.) that it uses to 
execute queries and retrieve annotation data for E. coli. EVA supports RegulonDB versions 
9.1, 9.2, and 9.3, and 9.4. RegulonDB version 9.1, corresponds to EcoCyc version 19.5 
(Keseler et al.) and the E. coli K-12 MG1655 genome version U00096.2 (Riley), while later 
versions correspond to EcoCyc versions 20.0, 20.1, and 20.5, respectively, and E. coli K-12 
MG1655 genome version U00096.3 (Hayashi et al.). EVA additionally requires a 
supplementary database derived from EcoCyc 21.0. All accessed databases and short read 
alignment algorithms should use the same version of the genome for compatibility when 
referencing absolute positions on the genome. E. coli strains that are highly similar to 
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MG1655 can also benefit from EVA. To do so, researchers must first align short-read data to 
the reference genome that corresponds to their installation of RegulonDB. EVA output refers 
to reference genome position coordinates in MG1655, but annotations and analysis will 
generally be consistent. Inherent differences between MG1655 and an alternate strain will be 
present across all samples and EVA will not consider these variations during network 
construction. 
For each mutation, EVA queries the RegulonDB database for features that coincide 
with the specified mutation region. During the annotation step, EVA considers all 
RegulonDB objects with defined absolute positions on the genome. The RegulonDB database 
maintains such data for genes, promoters, ribosome binding sites (RBS), terminators, 
attenuators, sRNA binding sites, riboswitches, and transcription factor binding sites (TFBS) 
and we refer to these as genomic features. Figure 2.2 gives an overview of several genomic 
features and their roles in E. coli. A mutation may coincide with multiple genomic features or 
no genomic features. By default, EVA does not annotate regulatory features for which the 
entire regulon also occurs inside the mutation to avoid network representation of mutated 
regulators that have no known added effect on the organism when a mutation is large. Users 
may change this setting to report all features in a region if desired. To reduce computation 
time for large mutations, EVA will only annotate coding regions. The default threshold for 
this behavior is 1 kilobase (kb) but users can change this to an alternative size. 
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Figure 2.2  Gene model 
A gene regulation model for a bacterial system. Proteins that bind at TFBS regulate 
transcription of the DNA template strand. The promoter is responsible for recruiting RNA 
polymerase and transcription begins at the transcription start site (TSS). Transcription 
continues through genes A, B, and C until RNA polymerase stalls at the termination stop 
point (TSP). This may occur due to either a terminating hairpin followed by a U track, or 
Rho factor, which is recruited at the Rho utilization (rut) site. Translation of mRNA is 
regulated by antisense sRNAs, riboswitches, and RBSs that contain the Shine-Dalgarno 
sequence. 
 
Analysis and Prioritization 
Automating the analysis and prioritization of mutated features enables investigators to 
distinguish between mutations predicted to be damaging from mutations predicted to be 
tolerated. EVA employs different analysis strategies for mutations in coding regions, 
structural features and RNAs, and binding sites, but the design allows for additional methods 
to be incorporated in the future. This section presents the implemented strategies for 
analyzing and prioritizing annotations for supported genomic features. 
 
Genes 
EVA classifies mutations that correspond to genes that encode proteins by the 
resulting change in the amino acid sequence and assigns high or low priorities based on the 
predicted severity of impact as outlined in Error! Reference source not found.. The 
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reference nucleotide sequence refers to the wild-type gene sequence in the reference genome. 
From this sequence, EVA derives an alternate nucleotide sequence by substituting the 
corresponding region in the reference sequence with the alternate mutation sequence. In 
some cases, constructing the alternate sequence requires additional processing. For example, 
in the case of a frameshift or deletion of the stop codon, the alternate gene sequence is the 
DNA sequence that begins at the gene start codon and extends to the first recognized stop 
codon. EVA classifies mutations that encompass a gene or modify the start codon without 
resulting in an alternate start codon as knockouts (KO) or loss of start codon and does not 
perform further analysis. 
Table 2.1  Prioritization of mutations in protein-coding genes 
Provean scores ≤ -2.5 are predicted to be damaging and are assigned a high priority. Scores 
not meeting the cutoff are predicted to be tolerated. In cases where a score cannot be 
computed, the priority is undefined and the mutations require further review by the 
investigator. 
Variation Description 
Low priority  
Silent No change in amino acid sequence. 
Alternate Stop Stop codon is replaced with an alternate stop codon. 
High priority  
KO Entire gene has been deleted or altered. 
Alternate Start Start codon is replaced with an alternate start codon. 
Start Loss Loss of start codon. 
Nonsense Substitution of one amino acid for a stop codon. 
Determined by 
Provean score 
 
Missense Substitution of one amino acid. 
Deletion Deletion of one or more amino acids. 
Insertion Insertion of one or more amino acids. 
Delins Deletion followed by insertion of one or more amino acids. 
Frameshift+ Out-of-frame insertion. 
Frameshift- Out-of-frame-deletion. 
Read-through Loss of stop codon results in read-through to next stop codon. 
Duplication Duplication of an amino acid sequence. 
 
 26 
Prioritization of mutations that result in variant amino acid sequences is based on 
Provean scores. We compiled libraries of supporting sequences for the E. coli U00096.2 and 
U00096.3 transcriptomes to improve performance and avoid the time-consuming homology 
search for each gene annotation. Libraries were generated using Provean version 1.1.5, NCBI 
BLAST version 2.4.0+, CD-HIT version 4.6.4, and the NCBI BLAST non-redundant 
sequence database (last updated on January 12, 2015) using Cyverse resources (Merchant et 
al.). 
EVA translates both the reference and alternate nucleotide sequences to amino acid 
sequences using the bacterial genetic code specified in NCBI translation table 11. If there 
exists no difference between the reference and alternate amino acid sequences, the gene 
mutation is silent. Where possible, EVA produces variation descriptions using HGVS 
nomenclature from the reference and alternate amino acid sequences. EVA generates this 
description by calculating the greatest common prefix and greatest common suffix of the 
reference and alternate amino acid sequences, assessing the sequence variation, and selecting 
the proper HGVS descriptor for the change in amino acid sequences. 
Because Provean only supports certain HGVS formats as input, EVA classifies amino 
acid variations as missense (single amino acid substitution), nonsense (premature stop 
codon), insertion (insertion of one or more amino acids), deletion (deletion of one or more 
amino acids), delins (deletion followed by an insertion), or duplication (duplication of amino 
acid region). EVA converts other mutations, such as frameshifts, into delins when possible. 
The reference amino acid sequence and HGVS variation description are submitted for 
Provean analysis. 
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EVA prioritizes gene annotations based on mutation type and Provean results. Silent 
mutations and those predicted to be tolerated (default threshold is a Provean score > -2.5) 
receive low priority, as they are unlikely to affect protein function. KOs, loss of start codons, 
and mutations predicted to be damaging are most likely to destroy protein function and are 
assigned high priority. Nonsense mutations and frameshifts are typically given a high priority 
unless they occur toward the end of the coding sequence. In some cases, such as a low 
number of sequence homologs, the Provean analysis may not be relevant, and EVA regards 
the priority as unassigned. 
 
Structural Features and RNAs 
Annotations corresponding to terminators, attenuators, riboswitches, and RNA 
genomic features are analyzed for changes in secondary structure. The reference nucleotide 
sequence refers to the wild-type genomic feature sequence in the reference genome. EVA 
constructs an alternate nucleotide sequence by substituting the region in the reference 
sequence that corresponds to the mutation with the alternate mutation sequence. The 
RNAfold methods in the Vienna RNA package (Hofacker, 2003) predict the secondary 
structure and calculate minimum free energy (MFE) for the reference and alternate 
sequences. The RNAfold mfold algorithm uses dynamic programming to predict an 
energetically stable model of an RNA molecule by minimizing its free energy. The energy 
model sums contributing free energies from loops to calculate the total free energy score of a 
secondary structure. 
Comparing the MFE (in kcal/mol) for reference and alternate sequences reveals if the 
mutation affects the secondary structure stability; a smaller MFE in the alternate sequence 
indicates greater secondary structure stability while a larger MFE indicates reduced 
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secondary structure stability. For example, a mutation in a terminator that reduces MFE of 
the predicted secondary structure suggests a higher likelihood of forming its stem-loop 
structure and stopping transcription. To offer context for the change in MFE, we simulate 
variations of the reference sequence and calculate the MFE for each variation. Variant 
sequences include single nucleotide deletions, insertions, and substitutions at each position. 
With insight into the energy landscape of the molecule subjected to small variations, we can 
compare the change in MFE caused by the mutation with other minor sequence changes. 
Calculating the Levenshtein distance (Levenshtein), or another metric such as a mutual 
information score, for aligned structures in dot-bracket notation captures the change in 
predicted secondary structure. 
A change in predicted secondary structure may impair or destroy the function of 
regulatory elements or disrupt protein folding. Thus, if the change in MFE exceeds a user-
defined cutoff (e.g., greater than 1 standard deviation from reference) or the Levenshtein 
distance exceeds a threshold, EVA assigns annotations a high priority. EVA assigns a low 
priority to annotations corresponding to mutations that result in small changes in MFE or do 
not significantly alter the predicted secondary structure. Because computational requirements 
for secondary structure prediction grow exponentially with sequence length, EVA limits 
predictions to sequences with length less than 1 kb, but users may override this setting or 
independently run predictions. If secondary structures are not predicted, EVA considers the 
priority to be unassigned. 
 
Binding Sites 
EVA searches relevant genomic feature sequences to ascertain if the alternate 
sequence of a mutated feature is a known binding site sequence in E. coli. This is performed 
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by querying the RegulonDB database for unique sequences with the same function (e.g., all 
σ28 promoters or all TFBS to which the transcription factor Fis is predicted to bind). If the 
alternate sequence is a known binding site, while the mutation may change binding site 
affinity, EVA predicts it to remain functional and assigns a low priority. Otherwise, EVA 
assigns the annotation a high priority. 
For σ70 promoters, the most prevalent class of promoters and the class associated with 
the primary sigma factor during exponential growth, EVA may perform an alternative 
analysis. Kinney et al. developed a procedure known as Sort-Seq to create a predictive map 
for the E. coli RNAP as they bind to DNA (Kinney, Murugan, Callan, & Cox). Their 
experiment characterized over 200,000 variations on a 75 bp region of the lac promoter and 
CRP binding site and authors inferred energy matrices that described the CRP-DNA and 
RNAP-DNA interactions. 
Despite the complexity of protein-DNA interactions, it has been shown that a 
sequence-dependent linear model sufficiently describes binding energy for DNA-protein 
interactions (Benos). Each base in the DNA sequence is modeled as having an independent 
contribution to overall binding affinity. Thus, given parameters defined in (Kinney et al.), the 
binding energy of RNAP to a specific DNA sequence is the sum of energy values from 
contributing bases along the sequence. 
EVA annotates the -10 and -35 elements of a promoter as separate genomic features, 
thus Sort-Seq scores are calculated independently for each promoter element. EVA only 
scores substitutions in promoter elements that are the same size as those in the Sort-Seq 
matrix, 6 bp, which is also the predominant promoter element size. A specific promoter 
element size is not a limitation of the Sort-Seq experimental method, and if alternate 
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sequence lengths were measured, EVA could appropriately penalize insertions and deletions 
inside promoter elements. For a substitution in a σ70 promoter feature that is 6 bp, EVA 
assesses if the Sort-Seq score for the reference (wild-type) promoter differs from the alternate 
promoter sequence resulting from a mutation. Following the assumption that gene expression 
is proportional to the probability that RNAP is bound, it follows that an increase in binding 
affinity will result in an increase in mRNA abundance and a decrease in binding affinity will 
result in a decrease in mRNA abundance. If there is no change, EVA classifies the annotation 
as low priority, otherwise, EVA assigns a high priority. 
 
Gene regulatory and metabolic network generation 
Annotations and mutation analysis only suggest direct effects of changes in the 
genome. EVA utilizes gene regulatory and metabolic network data to visualize downstream 
features to assess the indirect effects a mutated genomic feature can have on regulated 
features. EVA generates a biological network by retrieving downstream features of the 
mutated feature via transcription and translation regulation and signaling and metabolic 
pathways. The expanded collection of elements forms a gene regulatory and metabolic 
network. In this network, nodes are biological features such as genomic features, gene 
products, transcription factors, transcription units, reactions, and pathways (Figure 2.3). 
Directional edges denote interactions such as transcription regulation, translation regulation, 
and catalysis or relationships such as a gene encoding a protein, a transcription unit 
comprising genes, or a reaction belonging to a pathway. Clustered nodes can show 
relationships between mutations and biological systems relevant to organism fitness. 
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Figure 2.3  Combined gene regulatory and metabolic network structure 
Nodes representing regulators that map to absolute positions on the genome are represented 
in rectangles (e.g., promoters, terminators). Genes are represented by ovals, transcription 
units (TU) by parallelograms, gene products by diamonds, reactions (RXN) by triangles, and 
pathways (PWY) by hexagrams. Mutations are annotated with operons only if no other 
annotation is available. The operon region spans the transcription units as well as regulators 
of the transcription units. Directed edges link nodes based on regulatory activities, 
transcription, translation, and enzymatic activity. Gene regulatory data are obtained from 
the RegulonDB database and reaction and pathway data, shaded in the figure, are obtained 
from EcoCyc. The default EVA network bypasses TU features and connects regulators 
directly to genes. TF and sRNA nodes bypass binding sites in favor of edges to regulated 
genes. TFBS and sRNA BS are only represented if they have an associated mutation. 
 
For network construction, the default behavior is to convert annotations into a set of 
genomic features, each with an associated list of strains. When a user submits more than one 
strain for analysis, EVA ignores features that contain mutations in all strains during network 
construction. This is done to eliminate background variations from the network for strains 
highly similar to E. coli K-12 MG1655 and variations propagated from ancestral strains. 
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EVA additionally gives an option to produce networks for each derivative sample with 
variations common to ancestral strains removed. 
For each genomic feature, EVA creates a seed node representing the feature and 
initializes a branch, a directed, rooted network which may contain cycles, with the seed node 
as the root. To build the branch, EVA adds outward edges and nodes recursively until a user-
defined number of transcription and/or translation regulation steps, n, is reached (default n = 
1). Network construction does not penalize other types edges (i.e., relationship designations 
between nodes, such as a reaction belonging to a pathway) in this process. If a node is a 
regulator, biological features controlled by the regulator and interaction edges are added to 
the network. If the node is a gene, the gene product, associated enzymatic reactions and 
associated biological pathways are added to the network along with appropriate edges. If the 
node is a transcription unit, genes within the transcription unit are added to the network with 
edges connecting the transcription unit to the genes. This process continues up to n regulation 
steps. 
EVA constructs a branch for each genomic feature with one or more associated 
mutations. Finally, EVA merges all branches into a single network that represents mutated 
elements and their downstream features. EVA, by default, will generate a network that 
merges some linear relationships to reduce network size, however an option to represent all 
features is available. In addition, EVA produces two alternative networks to aid in biological 
interpretation: a mutation interaction network, and a shortest-paths network. The default 
network produced by EVA contains all biological features that can be reached within n 
regulation steps of a variant genomic feature, where n is a parameter specified by the user at 
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runtime. This network represents all potential downstream biological features that one or 
more mutations may affect and which may contribute to the phenotype of a derivative strain. 
The mutation interaction network is a subset of the default network formed of all 
paths from seeds to nodes reachable by two or more seeds. Thus, leaf nodes and most internal 
nodes are biological features that multiple mutations may affect indirectly. While mutations 
may individually yield a specific phenotype, this network can reveal potential interactions 
among mutations which could be synergistic, additive, or antagonistic. The shortest-paths 
network is a minimal representation of potential interactions among seeds. EVA constructs 
this network from all shortest paths, measured by the number of edges, from pairs of seed 
nodes to common nodes among branches. This visualization offers a minimal summary of 
EVA results which diminishes contributions of large regulators, such as transcription factors, 
which can overwhelm the network. Every network depicts all seed nodes even if they are 
isolated with degree zero. A single node attribute file may be used for all representations. 
EVA writes attributes and network files to files that can be imported into Cytoscape 
(Shannon, 2003) for visualization. A Cytoscape style has also made available with EVA. 
 
Software implementation 
The EVA core software was developed in Java. A local copy of RegulonDB with 
supplemental tables utilizing metabolic network information from EcoCyc was used. A 
PROVEAN library for E. coli genes was created for faster mutation analysis. Source code is 
available under an open source license at https://github.com/eboggess/EVA. 
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Results 
For the following experiments, short read data alignment to E. coli K-12 MG1655 
(U00096.3) and SNP-calling was performed using Breseq 0.31.0 (Deatherage & Barrick) 
with Bowtie2 2.3.2 (Langmead & Salzberg) and R 3.4.1. A local installation of RegulonDB 
9.4 was used to annotate mutations and retrieve biological feature interactions for network 
construction. A local copy of a supplemental database derived from EcoCyc 21.0 was used to 
incorporate reaction and pathway data into biological networks. Secondary structure analysis 
was performed with the Vienna RNA package 2.3.2 and amino acid sequence variations were 
score using Provean 1.1.5 with CD-HIT 4.6.4 and NCBI blast 2.4.0+. All ancestral and 
derivative strain mutation data was submitted to EVA as Genome Diff files and default 
options were used in the analyses. 
 
Antibiotic resistance in E. coli 
This section compares the genomic mutations identified and analyzed in work by 
Wang et al. (Wang et al.) with the expanded analysis provided by EVA. In the metabolic 
evolution experiment performed by Wang et al., E. coli K-12 MG1655 was used as the parent 
strain and exposed to antibiotics with the goal of generating a strain that exhibits antibiotic 
tolerance and identifying mechanisms of drug resistance. Fifty parallel populations of the 
ancestral strain were exposed to antibiotics Ciprofloxacin (Cpr), Neomycin (NeoB), a Cpr-
Neo hybrid (Hyb), a Cpr/NeoB equipolar mixture (EqP), and a Cpr/NeoB equimolar mixture 
(EqM). Four parallel populations were grown with no evolutionary pressure as a control 
(Ctrl). At the conclusion of the experiment, genome sequencing was performed, short read 
data were aligned to the E. coli K-12 MG1655 (U00096.2) genome (Riley) with Bowtie2, 
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and mutations were predicted using SAMtools and Dindel (Albers et al.). One hundred 
eighty-four unique mutations corresponding to 93 genes and 5 tRNAs were predicted in one 
or more strains evolved for drug resistance and 6 mutations were annotated with the nearest 
gene. 
We applied the EVA pipeline to the genomic data from Wang et al., beginning with 
short-read alignment and SNP-calling with Breseq. Raw SNP-calling results include 
instances where only reads aligned in one direction support an alternate base call. This may 
be an artifact from errors in library preparation or sequencing, or an error in the alignment 
process (Guo et al.). Breseq uses a Fisher's exact test for biased strand distribution and a 
Kolmogorov-Smirnov test for lower quality reads supporting the alternate sequence to reduce 
false positive SNP calls. Our analysis using Breseq can detect more complex variations, such 
as large deletions, and is more accurate in more accurate in finding mutations. In total, 
Breseq predicts 232 unique mutations among the 54 samples, including 182 of the mutations 
predicted by Wang et al. The 50 new mutations correspond primarily to large insertions and 
deletions the earlier method may not detect, but 16 are previously unreported single 
nucleotide variants (SNV) and small insertions or deletions (less than 10 bp). Breseq detects 
the reported 2 bp insertion in yqgE but excludes it from analysis due to low-quality base calls 
for the alternate sequence and strand bias in the alignment. Discrepancies exist between the 
results, including a predicted 7 bp insertion after dnaG not in our results. Wang et al. predict 
a 3 bp deletion (TGG) at relative position 1787 of 2145 in pta, but our results instead have a 
3 bp deletion in pta at relative position 1789. Finally, our results do not have the SNV in fusA 
that Wang et al. predicts for six samples in the NeoB-08 sample. 
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Breseq Genome Diff output files for the ancestral and derivative strains were 
provided to EVA as input for mutation analysis. EVA produces 266 annotations for the 
predicted mutations, meaning that some mutations spanned more than one genomic feature. 
EVA reports 17 annotations that correspond to regulators not represented in Breseq output 
and annotations corresponding to insertion sequences, pseudo genes, and operons for five 
mutations. Table 2.2 provides a summary of selected results and full details are available in 
an additional file. 
Table 2.2  A selection of previously unreported predicted mutations in antibiotic-resistant 
strains 
Annotations are listed alphabetically by name along with the corresponding antibiotic 
treatment(s) and assigned priority are provided for each annotation. The acrA attenuator, 
gntR terminator, sulA promoter, and LexA binding site are EVA annotations not provided by 
Breseq output. 
Annotation Antibiotic(s) Priority 
acrA attenuator HyB High 
cra Hyb High 
cyoE-ampG NeoB  High 
emrR  EqM  High 
fre  NeoB  High 
ftsZ  EqM  Low 
gntR terminator EqM Low 
icd  Cpr, EqM, Hyb Low 
lexA HyB High 
nikA  EqM  High 
nuoC  NeoB  High 
rhsC  EqP  Low 
rimK, ybjN, potF, potG, potH, potI Cpr  High 
rrlC  EqP  Undefined 
sucD  HyB  High 
sulAp / LexA TFBS EqP Undefined 
tamA-tamB EqP  High 
tufB  EqP  High 
waaQ Hyb, EqP  High 
yaiU-[yaiW]  NeoB  High 
yqjI  EqM  High 
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EVA excluded genomic features with any mutation in all 54 samples from network 
construction. The gene regulatory and metabolic network for the experiment is built from 
seed nodes that represent the remaining 164 features. Network summary statistics are 
provided in Error! Reference source not found.. Network size was reduced by more than 
half in the mutation interaction network, primarily due to the exclusion of the LexA regulon. 
Cytoscape was used to visualize the simplified shortest-paths network shown in Figure 2.4A. 
Table 2.3  Summary of nodes and edges in biological networks generated by EVA. 
The default network includes all nodes and edges. The mutation interaction is a subset of the 
default network comprised of nodes representing mutated features and edges that connect 
them. The shortest path network further reduces the number of nodes and edges by including 
only the shortest paths between mutated features. 
Network Nodes Edges 
Antibiotic-resistant (161 
seed nodes) 
    
Default 1122 1329 
Mutation interaction 503 621 
Shortest Path 325 270 
Benzoate tolerant (104 seed 
nodes) 
    
Default 797 1008 
Mutation Interaction 437 598 
Shortest path 234 200 
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Figure 2.4  Network visualization of mutations in antibiotic resistant strains 
A. Cytoscape visualization of the EVA shortest-paths network (325 nodes, 270 edges) derived 
from predicted variant genomic features in antibiotic-resistant strains. Red indicates seed 
nodes representing features assigned a high priority, orange indicates unassigned priority, 
and green indicates low priority. The network includes up to 1 level of transcription or 
translation regulation downstream of a mutated feature. B. The largest cluster in the 
antibiotic resistance network is the Cra regulon, marRAB operon, and the multidrug effux 
system. C. A selection from the cluster in B that feature the LexA regulon and SOS response 
system. This subset is connected to the remainder of the cluster in B via the peptidoglycan 
maturation pathway node. 
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Cra regulon, marRAB operon, and multidrug efflux system 
Breseq detected evidence of an unreported 12 bp deletion within the cra gene at 
position 88,827 in the Hyb-10 sample. The predicted mutation results in an out of frame 
deletion beginning at amino acid position 267 of 335 in Cra and is represented in HGVS-
style notation as D267_I270del. Due to the severity of the deletion (Provean score -15.83), 
EVA predicts the mutation to be damaging to Cra, a transcriptional dual regulator. 
Examining the gene regulatory network shows Cra is a predicted repressor of the marRAB 
operon. Previously, Wang, et al. hypothesized that the hybrid drug could evade the marRAB 
drug efflux, which would make it unique among quinolone drugs. While the predicted cra 
mutation occurs in only one hybrid strain, PCR verification of the deletion and measuring 
transcript abundance of marRAB genes could reveal if regulation affects the operon and if 
this is a strategy for hybrid drug resistance. 
Examination of all predicted mutations in the gene regulatory and metabolic network 
illustrates how both Cra and AcrR, a marRAB repressor corresponding to mutations reported 
by Wang et al. regulate the marRAB operon. Instances of mutations in acrR appear in all 
strains except those evolved for NeoB resistance. EVA provides a second annotation for a 
SNV within acrR that corresponds to an acrA attenuator (terminator) (C to A at position 
485,010 in strain Hyb-09). The MFEs of the reference and alternate sequences sequence -
5.70 and -0.30 kcal/mol, respectively, showing a lower likelihood for the terminator structure 
to form which would result in an increase in acrA transcription. Provean predicts the 
mutation in AcrR to be damaging with a score of -4.60. Damaged AcrR could result in 
weaker repression of the marRAB operon and increased abundance of the marRAB transcript. 
Because this mutation appears in many strains, including one Hyb strain, there is strong 
support that altering the AcrR transcription factor is a strategy for antibiotic resistance. 
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Network visualization in Cytoscape shows the relationship between these regulators 
and two other multidrug resistance genes; mprA and emrY (Figure 2.4B). The emrY mutation, 
which is silent, was previously identified in EqP-02, but the 69 bp deletion that affects mprA 
(also known as emrR) had not been reported. MprA is a transcriptional repressor that is 
predicted to regulate the acrAB operon. Damage to MprA could decrease repression of acrAB 
and subsequently increase drug transmembrane transport. 
 
LexA regulon 
LexA is a transcriptional repressor responsible for regulating the SOS response, the 
cellular response to DNA damage or inhibition of DNA replication (Janion). EVA assigns the 
point mutation Wang et al. reported within lexA a high priority based on the Provean score of 
-7.63 which predicts the corresponding P107Q amino acid variation to be damaging. The 
SOS response can promote mutations, which increases the opportunity to acquire antibiotic 
resistance (Cirz et al.). By damaging the LexA repressor, the SOS pathway may be de-
repressed, enabling increased transcription of error-prone SOS-regulated polymerases. 
In addition to the LexA mutation, which EVA predicts to be damaging with a 
Provean score of -7.61, a previously unreported SNV in EqP-09 (A to G at position 
1,020,956) corresponds to both the -10 element of the sulA promoter and a LexA binding site 
(Figure 2.4C), which acts as a transcriptional repressor for sulA. SulA is a cell division 
inhibitor which has been shown to be involved in stress-induced point mutations (McKenzie, 
Harris, Lee, & Rosenberg). 
An unreported 12 bp deletion inside ftsZ in EqM-06 results in an amino acid sequence 
change described by EVA as P346_Q349del. FtsZ, which is essential for cell division, is a 
known antibiotic target and is inhibited by SulA (Cordell, Robinson, & Lowe). Despite 
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deleting four amino acids from FtsZ, Provean predicts the mutation to be tolerated with a 
score of -0.599 and EVA assigns a low priority. While predicted mutations in LexA and its 
regulon occur in distinct strains adapted for under different conditions, the SOS response 
system may be a relevant antibiotic resistance strategy for both drug mixtures and the hybrid 
drug. Further experimentation is necessary to examine the variant sulA promoter strength and 
changes in sulA and ftsZ transcripts and discern relevance to fitness. 
 
Benzoate tolerance in E. coli 
In this section, we compare genomic mutations identified and for benzoate-adapted 
strains (Creamer et al.) with the analysis provided by EVA. The benzoate evolution 
experiment performed by Creamer et al., used E. coli W3110 as the parental strain and 24 
cultures were subjected to increasing benzoate concentrations up to 20 mM. The Illumina 
MiSeq platform was used for genomic sequencing of 16 benzoate-evolved strains and the 
parent strain. Creamer et al. used Breseq to assemble short-reads and identify of genomic 
variants. 110 mutations were predicted in one or more evolved strain, but not the parent 
strain. 
For our analysis, we repeated the short-read assembly and annotation using Breseq 
and used E. coli K-12 MG1655 U00096.3 as the reference genome for compatibility with 
EVA. Because the strains are highly similar, the 136 mutations predicted by Breseq are 
generally consistent with those reported by Creamer et al., but with MG1655 genome 
position coordinates. From these 136 mutations, EVA finds 188 corresponding genomic 
features, of which 104 features are not mutated in all strains. 
In addition to results reported by Creamer et al., EVA annotates nine mutations 
previously only recognized as intergenic and adds regulatory feature annotations to three 
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reported gene mutations (Table 2.4). The network generated by EVA links the missense 
mutation in rob with the marRAB operon which is deleted from the genome in several strains. 
Genes cpxA, emrY, and emrA appear separately as they are part of a signal transduction 
system and efflux pumps. The Provean score for the L191M amino acid mutation in MdtA 
does not meet the minimum criteria and EVA considers it a low priority mutation. For one 
mutation in gene fdnG, a Provean analysis was not performed due to a selenocysteine site 
which appears as an internal stop codon during translation; a scenario for which EVA is 
unable to provide analysis. 
Creamer et al. noted there must be factors besides those reported which are 
responsible for fitness advantage and chloramphenicol sensitivity based on their strain 
characterizations. Specifically, the authors hypothesize that the C3-1 genome may have 
defects in other multidrug resistance genes, G5-2 must have unknown mutations that 
contribute to chloramphenicol sensitivity and benzoate fitness, and E1-1 maintains 
chloramphenicol resistance, unlike other strains. To further investigate variations in the 
phenotype among evolved strains, we examine the predicted mutations in the combined gene 
regulatory and metabolic network representation generated by EVA. 
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Table 2.4  Previously reported intergenic mutations in one or more benzoate-tolerant strains for which EVA provides annotations. 
Mutations are ordered by genome position. 
Mutation Previously reported annotation EVA annotation Priority 
29617, A → G intergenic (+422/-34), dapB → / → carA ArgR TFBS (repressor) Undefined 
573671, T → A intergenic (+109/+289), ybcQ → / ← insH ipeX Undefined 
1337160, G → A intergenic (+617/-385) cysB → / → acnA yciX Low 
1553904, 2 bp → CT intergenic (+199/+207), fdnI → / ← yddM C0362 Low 
1553926, T → C intergenic (+199/+207), fdnI → / ← yddM C0362 Low 
1565001, A → G intergenic (-211/+47), ddpX ← / ← dos Rho-independent terminator  Low 
1908956, IS5 (–) +4 bp coding (191-194/210 nt), cspC ← rlmA Attenuator (anti-terminator) High 
1908956, IS5 (–) +4 bp coding (191-194/210 nt), cspC ← Riboswitch High 
1909258, IS1 (+) +9 bp coding (40-48/144 nt), yobF ← Riboswitch High 
2441649, C → T intergenic (-44/-115), fabB ← / → trmC fabBp Undefined 
4218986, IS5 (–) +4 bp intergenic (+187/-79), metA → / → aceB aceBp High 
4470927, G → A intergenic (-67/+52), treB ← / ← treR treB Attenuator (terminator) Undefined 
4639891, A → G S34P (TCC→CCC)  rob ← (in addition to rob) creAp Low 
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Several regulators are predicted to contain mutations, including a dosCP terminator, 
fabB promoter, and aceBAK promoter. The point mutation in the dosCP terminator in the E1-
1 clade is interesting because it is upstream of ddpX, a D-Ala-D-Ala dipeptidase involved in 
resistance to antibiotic vancomycin (Lessard & Walsh). However, the resulting sequence 
change does not affect MFE of the predicted secondary structure and transcriptomic analysis 
of ddpX is required to determine if the mutation has any effect. The point mutation in the 
fabB -10 promoter element in all strains in the G5-2 clade results in a more favorable 
sequence for σ70 binding. An insertion sequence is detected inside the -10 promoter element 
for aceBAK in the E1-1 clades. Separately, a point mutation that is predicted to be damaging 
is found in aceA in all strains in the C3-1 clades (Figure 2.5). These mutations may represent 
different strategies to manipulate glyoxylate metabolism in benzoate adapted strains. 
EVA annotates a mutation previously reported in an intergenic region with the small 
RNA ipeX. The point mutation in ipeX in the A5-1 clades results in a higher MFE and thus a 
less favorable secondary structure. The small RNA ipeX has been shown to inhibit expression 
of outer membrane porins ompC and ompF through post-transcriptional modification 
(Castillo-Keller, Vuong, & Misra). 
EVA identifies a relationship between previously reported mutations in the genes add 
and deoD. The gene add contains a frameshift mutation in all strains in the G5-2 clade and 
deoD contains a predicted damaging SNP in G5-1. These genes are connected by the purine 
salvage pathway (Figure 2.5). Separately, strains in the E1-1 clade contain a mutation 
predicted to be damaging in the apt gene, which encodes another purine salvage enzyme. 
Purine metabolism is affected by antibiotics and has been proposed as a drug target for 
resistant bacteria (Møller et al.). Network statistics are provided in Table 2.3. 
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Figure 2.5  Network visualization of mutations in benzoate-adapted strains 
The shortest-paths network (234 nodes, 200 edges) generated by EVA analysis of benzoate-
adapted strains. Nodes are highlighted by priority; high priority: red, unassigned: orange, 
low: green. The largest cluster in the shortest-paths network (125 nodes, 167 edges) contains 
the mutated transcription factor Rob and mutated the fabB -10 promoter element which have 
implications for fatty acid biosynthesis. Also represented in this cluster is the destruction of 
the aceBAK -10 promoter element in the E1-1 clade and a predicted damaging mutation in 
aceA in the C3-1 clade. 
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Discussion 
Most existing methods for mutation analysis are limited to genes and require 
researchers to convert nucleotide variations to amino acid mutations. Additionally, mutations 
in a single strain are analyzed independently, making the investigation of mutation 
interactions a difficult task. Our approach accepts multiple formats and mutation information 
for one or more strains, automates a significant portion of analysis, and generates a network 
of mutations and their downstream biological features. Because direct mutation interactions 
and those occurring through regulation can be observed in EVA networks, our method can 
provide insight into underlying mechanisms affected by genomic mutations and support 
researchers in characterizing variant strains. 
There remain many uncharacterized and poorly understood genomic features which 
could, in the future, be incorporated into the EVA pipeline. For example, when examining 
binding affinity of promoter sequences, we align a specific sequence to the lac promoter to 
use as a model. While the effect of gaps in the spacer region has been studied elsewhere, the 
energy matrix we employ as a scoring scheme does not address insertions and deletions. A 
meaningful penalty for gaps is not immediately clear as there is an absence of experimental 
data, however, this is not a limitation of the method presented by Kinney et al., and an 
expanded dataset could be included in the analysis. Strategies to analyze intergenic regions 
themselves, such as the distance between promoter elements could also be implemented in 
EVA. 
Additionally, work has been done to characterize RBSs and RBS-promoter pairs in E. 
coli (Kosuri et al.; Na, Lee, & Lee; Salis, Mirsky, & Voigt) and effects on gene expression 
from 5-UTR and sRNA binding variants have been examined (Holmqvist, Reimegard, & 
Wagner). As more libraries of binding site variants are generated and associated mRNA and 
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protein abundances quantified, more energy matrices will be available that will reveal how 
sequence variations affect phenotype. In the absence of binding site libraries and associated 
expression data, alignments of known binding site sequences to form positional weight 
matrixes could reveal acceptable variants similar to the method SIFT uses for coding regions. 
For TFBSs, motif data is retrieved from public databases (e.g., CollectTF (Kilic, White, 
Sagitova, Cornish, & Erill) and PRODORIC (Münch et al.)). Features such as Rho utilization 
sites are not currently available in public databases for E. coli, but as the Rho termination 
factor is believed to be responsible for terminating 20-50% of all mRNA synthesis in the 
organism (Koslover, Fazal, Mooney, Landick, & Block), this feature data would be a 
valuable addition to EVA. For mutated genes, mechanisms of transcription and translation 
efficiency, such as codon bias (Welch et al.) may help better understand silent mutations. 
Additionally, the Provean threshold could be recalibrated with the latest NCBI non-redundant 
database and specifically for bacteria. 
In order to develop phenotype predictions, an expanded gene list including genes in 
the biological networks generated by EVA can be annotated with Gene Ontology (GO) terms  
(Ashburner et al.). This may be performed for all samples to search for overall evolutionary 
trends among biological replicates or for individual samples to examine a specific phenotype. 
While any single variation may be relevant to organism fitness, enriched GO terms from the 
expanded gene list can indicate importance to organism fitness and may capture biological 
knowledge of gene functions not represented in the EVA networks. However, as mutations in 
regulatory elements and genes that encode transcription factors will add additional, and 
sometimes functionally-related, genes into the EVA network, analysis for overrepresented 
GO terms could benefit from giving these downstream genes less weight. 
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One shortcoming of the per-mutation approach employed by EVA during the 
annotation step is the inability to interpret mutations in the context of one another. For 
example, a single genomic feature may contain multiple predicted mutations, but EVA would 
evaluate these separately. Future versions may consider such cases for improved 
interpretation. Another enhancement could include the integration of transcriptomic data or 
other omics data in the biological network that EVA generates. 
 
Conclusions 
EVA provides a framework to aid scientists in interpreting genetic variations that 
occur in metabolic evolution experiments by expanding annotations, prioritizing mutations. 
Indirect effects of mutations can be found in the biological network created by EVA that 
contains mutated features, downstream elements, and their interactions. It is important to 
note that we do not seek to quantify the effects of mutations but to offer a method of 
interpretation and constructive ranking to promote relevant laboratory experiments to further 
characterize mutation effects. EVA highlights the critical role of regulators and the need to 
include them in evolutionary experiment analyses. Software automation of mutation analysis 
in EVA improves upon what is generally a manual process. EVA is a principled approach to 
mutation analysis that can be refined as mechanisms of regulation are better understood and 
researchers perform more high-throughput and quantitative experiments to characterize 
regulatory sequences. 
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Abstract 
Metabolic evolution is a valuable strategy for overcoming toxicity of target 
biorenwable chemicals, however reverse engineering of evolved strains is necessary to 
understand how the tolerance phenotype is achieved. Whole genome sequencing and 
mutation analysis are required to identify the genomic changes that occur during an evolution 
experiment and characterization of both single and multiple mutations is necessary to 
understand their individual and combined contributions to phenotype. Here, we analyze the 
genome of Escherichia coli evolved for improved exogenous octanoic acid tolerance and 
reconstruct mutations in the parent strain to determine their contribution to phenotype. We 
identified mutations in rpoC, basR, and basS in strains evolved for tolerance and an insertion 
sequence in waaG in the parent strain that was lost during the course of the experiment, 
restoring function. We find the repair of waaG to reduce the amount of extracellular 
polysaccharides produced by the cells as well as decrease leakage and improve the specific 
growth rate in an octanoic acid challenge experiment. The rpoC mutation further improves 
tolerance after waaG is repaired and the mutations in basS and basR are found to improve 
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cell membrane integrity. These results highlight strategies to overcome membrane damage as 
a result of octanoic acid toxicity as well as the importance of studying synergistic effects 
among mutations found in evolved strains. 
 
Introduction 
Fatty acids are of great importance in the industrial field (Jarboe, Royce, & Liu, 
2013) due to their wide applications as multifunctional precursors to produce various fuels, 
chemicals, and textile fibers (Dellomonaco, Fava, & Gonzalez, 2010; Perez, Richter, Loftus, 
& Angenent, 2013; Zhang, Yang, Yang, & Ma, 2009). So far, the production of industrial 
fatty acids relies heavily on a nonrenewable and unsustainable resource, petroleum 
(Dellomonaco et al., 2010; C. Zhang et al., 2009), which can lead to severe environmental, 
political, and economic consequences (Stephanopoulos, 2007). Therefore, it is necessary to 
develop new pathways to produce fatty acids using renewable and sustainable carbon 
feedstocks. In this respect, biocatalysts are attractive and promising. They have already been 
broadly applied to biorenewable industries for the production of various chemicals, such as 
ethanol, glycerol, 1, 3-propanediol, and lactic acid (Nikolau, Perera, Brachova, & Shanks, 
2008). Moreover, it is potentially feasible for researchers to engineer organisms to obtain 
target biocatalysts with significant ability to produce fatty acids by utilizing microorganisms 
that can naturally synthesize fatty acids with 12-18 carbons, the primary components of the 
cell membrane (Nikolau et al., 2008). So far, remarkable progress has been achieved by 
researchers for the realization of the production of fatty acids by biocatalysts on a 
commercial level (Jarboe, Liu, & Royce, 2011; Lennen & Pfleger, 2012; L. A. Royce et al., 
2014; L. A. Royce, Liu, Stebbins, Hanson, & Jarboe, 2013; Volker et al., 2014; Wu, 
Karanjikar, & San, 2014; Wu, Lee, Karanjikar, & San, 2014). 
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Researchers have found that fatty acids produced by microbes are toxic to the 
microbes themselves at concentrations below the desired yield and titer (Jarboe et al., 2013; 
Lennen et al., 2011; Volker et al., 2014), just like other attractive biofuels and biorenewable 
chemicals (Baer, Blaschek, & Smith, 1987; Huffer, Roche, Blanch, & Clark, 2012; Yomano, 
York, & Ingram, 1998). This is a major obstacle for boosting the yield and titer of fatty acids 
(Jarboe et al., 2013). The mechanism of the toxicity of fatty acid to Escherichia coli has been 
studied, and it was reported that fatty acids can lower the cell viability by damaging the cell 
membrane and decreasing intracellular pH (Jarboe et al., 2013; Lennen et al., 2011; L. A. 
Royce et al., 2014; L. A. Royce et al., 2013). Several groups have tried to overcome fatty 
acid toxicity in E. coli by employing different approaches. One strategy was to restore the 
cell membrane to improve cell viability by over-expressing the fatty acid biosynthesis 
regulator, fabR, and introducing two foreign acyl-ACP thioesterase genes in E. coli. 
However, the engineered E. coli did not show improved fatty acid productivity (Lennen et 
al., 2011; Lennen & Pfleger, 2013). Another approach was to delete the acyl-ACP synthase 
(aas) gene in E. coli, which resulted a decreased percentage of medium chain fatty acids in 
the membrane, increased tolerance to medium chain fatty acids, and a slightly improved yield 
of fatty acids (Sherkhanov, Korman, & Bowie, 2014). Finally, metabolic evolution was 
employed as a strategy to increase tolerance to short chain fatty acids (SCFAs) (L. A. Royce 
et al., 2013). The evolved strain resulting from the short-term adaptation experiment exhibits 
an increased SCFA tolerance phenotype and improved production titer of the SCFAs (L. A. 
Royce et al., 2015).  
Reverse engineering aims to both identify mutations that contribute to the phenotype 
of evolved strains and understand why these mutations are beneficial. It is a powerful tool to 
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elucidate the mechanisms behind the evolution experiments, which can be used as design 
strategies for improving tolerance and production in other engineered strains. Identifying and 
understanding the key mutations that support the evolved phenotype requires knowledge of 
what mutations occurred during the evolutionary engineering. Whole-genome sequencing is 
invaluable for finding genomic mutations (L. Royce, Boggess, Jin, Dickerson, & Jarboe, 
2013) and transcriptome analysis and metabolic flux analysis have been proven useful for 
revealing the underlying mechanisms of the mutations (Elliot N. Miller et al., 2009; E. N. 
Miller et al., 2009). After mutations are found, the next steps are to explore which mutations 
promote fitness, the mechanisms of how the tolerance to inhibitors has increased, and the 
functions of poorly-characterized enzymes and pathways involved in the evolved phenotype. 
For instance, in an isobutanol tolerance study, five mutations were identified as primarily 
responsible for increased tolerance, and glucosamine-6-phosphate was identified as an 
important metabolite for isobutanol tolerance in E. coli (Atsumi et al., 2010). Increasing 
furfural tolerance was achieved by silencing the NADPH-dependent oxidoreductase gene 
(yqhD and dkgA) in E. coli (E. N. Miller et al., 2009). The new glucose uptake system and 
mechanism of increased ATP level in the evolved strain has been well studied, which were 
the key mechanisms of improving succinate production in E. coli (X. Zhang et al., 2009). 
In this work, we applied reverse engineering to study E. coli strains evolved for 
increased octanoic acid (C8) tolerance. To understand the genotype-phenotype relationship, 
the whole-genome sequencing of the evolved and parent strains was performed. The parent 
strain, ML115, is a MG1655 derivative by knocking out three genes and adding an antibiotic 
marker (∆fadD, ∆poxB, and ∆ackA-pta:cmR) in order to inactivate the fatty acid beta-
oxidation pathway and two acetate production pathways. The order in which mutations were 
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acquired was also determined in this work. Reconstructed strains with both single and 
multiple mutations were used in phenotypic characterization experiments in order to identify 
individual and combined contributions to fitness. 
 
Materials and methods 
 
Strains, plasmids and bacterial cultivation 
All bacterial strains and plasmids used in this study are listed in Table 3.1 and Table 
3.2. E. coli DH5α was used as a cloning strain, while the parent strain E. coli ML115, and the 
evolved strain LAR1 were used in the genome modification procedures. All E. coli strains 
were grown overnight at 37°C with 250 rpm orbital shanking in 25 mL of MOPS minimal 
media (Wilmes-Riesenberg & Wanner, 1992) with 2.0% (w/v) glucose and chloramphenicol 
(35 µg/mL, if needed) in 250 mL baffled flasks. The overnight cultures were diluted to 0.05 
of optical density at 550 nm (OD550) for the octanoic acid tolerance test or diluted to 0.1 at 
OD550 for testing membrane leakage, membrane fluidity, cell hydrophobicity, and cell 
membrane composition. E. coli transformants were grown in media at 37°C, or 30°C, with 
chloramphenicol (35 mg/L), ampicillin (100 mg/L), kanamycin (50 mg/L), or spectinomycin 
(50 mg/L) as needed.
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Table 3.1  Plasmids used in this study. 
Plasmids Description Reference 
pKD4 FRT-Kan-FRT cassette template, AmpR, KmR  (Datsenko & Wanner, 2000) 
pKD46 λ Red recombinase expression plasmid, Ampr (Datsenko & Wanner, 2000) 
pCP20 FLP recombinase expression, AmpR, CmR (Datsenko & Wanner, 2000) 
pUC57-rpoC-A rpoC-A-FRT-Kan-FRT cassette template, KmR This study 
pUC57-rpoC-C rpoC-C-FRT-Kan-FRE cassette template, KmR This study 
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Table 3.2  Strains used in this study. 
All strains contain the CmR chloramphenicol resistance gene. 
Strain 
Mutations 
Editing Method Reference waaG IS 
removed rpoC basR basS 
ML115 
 
    (L. A. Royce et al., 2015) 
LAR1 * * *   (L. A. Royce et al., 2015) 
LAR2 * *  *  (L. A. Royce et al., 2015) 
ML115+waaGInD *    CRISPR/Cas9 This study 
ML115+rpoC*  *   Lambda Red This study 
ML115+basR* 
 
 *  CRISPR/Cas9 This study 
ML115+basS* 
 
  * Lambda Red This study 
ML115+waaGInD+rpoC* * *   CRISPR/Cas9 This study 
ML115+waaGInD+basR* *  *  CRISPR/Cas9 This study 
ML115+waaGInD+basS* *   * CRISPR/Cas9 This study 
ML115+rpoC*+basR* 
 
* *  CRISPR/Cas9 This study 
ML115+basR*+basS* 
 
 * * CRISPR/Cas9 This study 
ML115+waaGInD+rpoC*+basR* * * *  CRISPR/Cas9 This study 
ML115+waaGInD+basR*+basS* *  * * CRISPR/Cas9 This study 
LAR1+rpoC *  *  CRISPR/Cas9 This study 
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Whole-genome sequencing and mutation verification 
The genomic DNA of ML115, LAR1 and LAR2 was purified using the Qiagen Blood 
and Tissue kit. The Illumina Genome Analyzer II platform was used for high throughput 
sequencing with 77 bp (base pair) paired-end reads as described (L. Royce et al., 2013). All 
samples were run on a single lane. Breseq version 0.31.0, a pipeline for finding mutations in 
microbial genomes, was used to align short read data and predict mutations (Deatherage & 
Barrick, 2014). Bowtie2 version 2.3.3 (Langmead & Salzberg, 2012) and R version 3.4.1 (R 
Core Team, 2018) software were used in the breseq pipeline. The U00096.3 genome for E. 
coli K-12 MG1655 (Blattner et al., 1997; Hayashi et al., 2006) was used as the reference 
sequence to which short-read data from both parent and evolved strains were aligned. 
87.8,%, 91.0%, and 87.3% of reads were successfully aligned to the reference sequence for 
ML115, LAR1, and LAR2, respectively. Previous genomic interventions (∆fadD, ∆poxB, and 
∆ackA-pta:cmR) present in ML115 were verified as regions of missing coverage. 
When considering predicted mutations, we followed the filters recommended by 
breseq to reduce the number of false positives. A Fisher’s exact test was performed for the 
distribution of reads aligning in the forward and reverse direction for the reference and 
variant sequence. If the distribution skewed to favor alignment in one direction, this may 
indicate a sequencing error in reads on one strand. Additionally, a Kolmogorov-Smirnov test 
was performed to test if the base quality scores corresponding to variant sequences are lower 
than the quality scores corresponding to the reference sequence. 
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Genomic variations displaying neither strand bias nor lower quality scores compared to the 
reference sequence which are predicted in an evolved strain but not the parent strain (and 
vice versa) were selected as mutations of interest to be verified with polymerase chain 
reaction (PCR) and Sanger sequencing. 
Genes containing predicted genomic variations along with an additional 500 bp 
upstream and downstream of the coding region were sequenced in order to verify mutations. 
Target gene fragments were PCR amplified with Qiagen Taq PCR master mix, primers, and 
the genome of evolved strain was used as the template. All primers were designed by 
Primer3 software (Untergasser et al., 2012) and synthesized by Integrated DNA 
Technologies (IDT). The sizes of PCR products were initially examined on a 1% TAE 
agarose gel with a 1 Kb plus DNA ladder. Next, PCR products exhibiting the expected gene 
fragment size were purified by QIAquick PCR purification kits (Qiagen) and submitted to 
Iowa State University DNA facility for DNA sequencing. The sequencing results were 
aligned to the E. coli K-12 MG1655 genome using the online NCBI standard nucleotide 
BLAST software (https://blast.ncbi.nlm.nih.gov/Blast.cgi) to confirm the mutations. 
Mutations were verified by repeating all steps above using the genome of evolved strain and 
parent strain separately as templates. 
 
PCR-restriction fragment length polymorphism (PCR-FRLP) 
We applied RCR-FRLP to determine the order of mutations in evolved strains, which 
use cells culture saved after every transfer during adaptive evolution as DNA template. For 
the mutation in rpoC (A1256C), the 660 bp DNA fragment which includes the mutant point 
was amplified by PCR with the primers rpoCCF, rpoCCR, and DreamTaq Green PCR master 
mix 2X (Thermo Fisher Scientific). The PCR products were purified by DNA Clean & 
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Concentration kit (Zymo). Approximately 10 µl of purified PCR products were digested with 
restriction enzyme BsaJI (New England Biolabs) according to the manufacturer’s instruction. 
The restriction fragments were separated on a 1% TAE agarose gel with 1 Kb plus DNA 
ladder. The pair of primers basRCF and basRCR, and restriction enzyme SfcI were used for 
basR mutation. The basSCF and basSCR primers, and restriction enzyme FatI were used for 
basS mutation. For the waaG mutation, only waaGCF and waaGCR primers were needed. 
 
Genomic manipulations  
All genomic manipulations were carried out using either lambda red recombinase 
system (Datsenko & Wanner, 2000) or CRISP-cas9 system (Jiang et al., 2015). For the 
lambda red recombinase system, E. coli strains were first transformed by electroporation to 
harvest the pKD46 plasmid, and then the lambda red recombinases were induced by adding 
L-arabinose (2 mM). The kanamycin resistance cassette was amplified from plasmid pKD4 
by PCR using primers with flanking homologous regions for the target gene, except the 
rpoC(1256A)+kan, and rpoC(1256C)+kan cassettes which were synthesized by GenScript 
company. The purified PCR products were transformed into the electro-competent E. coli 
cells harboring pKD46, and lambda red recombinases system was induced. The resulting 
kanamycin resistant colonies were screened for the successful gene replacement by the PCR 
amplification, restriction enzyme digestion, and DNA sequencing. The scarless CRISPR-
Cas9 approach was also applied to achieve gene replacement in parent and evolved strains. 
 
Octanoic acid tolerance test 
Octanoic acid tolerance was determined by measuring OD550 every hour. Overnight 
seed cultures were inoculated into 250 mL baffled flasks, which contained 25 mL MOPS 
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with 2.0% (w/v) dextrose and 10 mM octanoic acid (1.44 g/L) with an initial media pH of 7.0 
and an initial OD550 of 0.05. The control groups used the same culture without the addition of 
octanoic acid. The flasks were incubated in a rotary shaker at 200 rpm and 37°C. Cultures 
were taken and measured at OD550 every hour.  
 
Determination of fatty acid titers 
Fatty acid production was quantified by measuring total fatty acids via an Agilent 
6890 gas chromatograph coupled to an Agilent 5973 mass spectroscope (GC-MS) after fatty 
acid extraction and derivatization (Torella et al., 2013). Briefly, fatty acid extraction was 
done as follows: 1 mL culture was transferred into a 2 mL microcentrifuge tube, 125 µL 10% 
NaCl (w/v), 125 µL acetic acid, 20 µL internal standard (1 µg/µL C7, C11, C15 in ethanol), 
500 µL Ethyl Acetate was added subsequently. The mixture was vortexed 30 seconds and 
centrifuged at 16000 g for 10 minutes, then the 250 µL top layer, which contained free fatty 
acid, was transferred into a glass tube. For the fatty acid derivatization part, 2.25 mL 30:1 
EtOH: 37% HCl (v/v) was added into the glass tube from fatty acid extraction part, incubated 
at 55°C for 1 hour, then cooled to room temperature. After this, 1.25 mL ddH2O and 1.25 ml 
hexane was added followed by vortexed and centrifuged at 2,000 × g for 2 minutes. The top 
hexane layer was then analyzed by GC-MS using the following programs: the initial 
temperature was set at 50°C, holding for 1 minute, with the following temperature ramp: 
20°C/minute to 140°C, 4°C/minute to 220°C, and 5°C/minute to 280°C with 1 ml/minute 
helium carrier gas. The relative retention factor of C7/C11/C15 was used to adjust the 
relative amounts of the individual fatty acids analyzed. 
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Membrane characterization 
 
Membrane permeability 
The seed culture was inoculated into 250 mL baffled flasks with 25 mL MOPS media 
with 2.0% (w/v) glucose. The flasks were incubated in a rotary shaker at 250 rpm at 37°C. 
Cells were then harvested at mid-log phase (OD550 ≈ 1) followed by centrifugation at 4,500 × 
g and 22°C for 10 minutes. The cells were then treated with PBS with 10 mM octanoic acid 
at pH 7.0, incubated at 37°C for 1 hour along with a control group to which no octanoic acid 
was added. Subsequently, cells were centrifuged at 4,500 × g at 4°C for 10 minutes, washed 
twice with PBS (pH 7.0), and resuspended in PBS at a final OD550 = 1. Then, 100 µL 
resuspended cell solution was diluted with 900 µL PBS. Cells with damaged membrane were 
stained by the addition of 1 µL of 5 mM SYTOX green in dimethyl sulfoxide (Invitrogen, 
Carlsbad, CA), and tested by flow cytometric analysis performed on the BD Biosciences 
FACSCanto II (Lennen & Pfleger, 2013). Approximately 18,000 events were tested per 
sample, and each sample had three parallel groups. 
 
Membrane fluidity 
Membrane fluidity was tested using 1, 6-diphenyl-1, 3, 5-hexatriene as previously 
described (Mykytczuk, Trevors, Leduc, & Ferroni, 2007; L. A. Royce et al., 2013). Briefly, 
E. coli cells were treated as described in membrane permeability section. Cell pellets were re-
suspended in PBS at a final OD550 = 1, then 500 µL resuspended cell solution was transferred 
into a 1.5 mL centrifuge tube which contained 500 µL 0.4 µM DPH, vortexed, and incubated 
at 37°C. Samples were then centrifuged and cell pellets were resuspended with 500 µL PBS 
(pH 7.0). 100 µL cell solution was transferred into sterile black-bottom Nunclon delta surface 
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96-well plate with 4 replicates, and the cell solution without DPH was used as blank. 
Membrane fluorescence polarization was measured using a Synergy 2 Multi-Mode 
microplate reader from BioTek. 
 
Cell surface hydrophobicity 
Cells were treated with MOPS with 2.0% (w/v) glucose and 10 mM octanoic acid at 
pH 7.0, incubated at 37°C for 1 hour along with a control group to which no octanoic acid 
was added. Un-adapted and 10 mM C8 adapted cells were washed twice with PBS, and 
resuspended in PBS (pH 7.0) to OD550 ≈ 0.6. Then, 4 mL cells were added to a glass tube and 
100 µL resuspended cells were used to measure OD550, recorded as OD1. Next, 1 mL 
dodecane was added to the glass tubes (Pembrey, Marshall, & Schneider, 1999). The glass 
tube was vortexed using a multi-tube vortexer (Thermo Fisher Scientific Inc., Waltham, MA, 
USA) at 2500 rpm for 10 minutes to homogenize the aqueous and organic phases. The glass 
tube was left to stand for 15 minutes to allow phase separation and the OD550 of the aqueous 
phase (OD2) was determined. Partitioning of the bacteria suspension is calculated using the 
following equation: 
!"#$"%&	()#&*&*+%*%, = 	./0 − ./2	+3	)45"+56	(ℎ)6"./0 ∗ 100 
 
Membrane lipid composition 
E. coli cells were harvested at mid-log phase, resuspended in 25 mL MOPS media 
with 2.0% (w/v) dextrose and 30 mM C8 at pH 7.0 and incubated for 3 hours at 37°C. The 
cells were washed twice in cold sterilized water and resuspended into 6 mL methanol. 1.4 
mL cells solution was transferred into glass tubes with three replicates (Bligh & Dyer, 1959), 
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and sonicated for three, 30 second bursts. A total of 20 µL of 1 µg/ µL C7, C11, and C15 in 
methanol was added as an internal standard. For fatty acid extraction, the glass tube was 
incubated at 70°C for 15 minutes and cooled to room temperature. The cells were centrifuged 
at 4000 rpm for 5 minutes. The supernatant was transferred into a new glass tube with 1.4 
mL nanopure water, and the mixture was vortexed. Chloroform with a volume of 750 µL was 
add into the cell pellets, vortexed and shaken in a horizontal shaker at 150 rpm, 37°C for 5 
minutes. We transferred the supernatant with H2O back to the cell pellets glass tube, vortexed 
for 2 minutes, then centrifuged at 3,000 rpm for 5 minutes. The lower chloroform layer 
which contain free fatty acid was transferred into a new glass tube. The free fatty acids were 
concentrated with an N-Evap nitrogen tree evaporator. For fatty acid derivatization, 2 mL of 
1N HCl was added in methanol to the samples. The free fatty acids were concentrated under 
nitrogen, heated to 80°C for 30 minutes, and then cooled to room temperature. 2 mL of 0.9% 
NaCl solution and 1 mL hexane was added and followed by vortex for 2 minutes and 
centrifugation at 2,000 × g for 2 minutes. The upper layer, the hexane with FAMEs, was 
transferred into a GC vial for analysis. The GC-MS was equipped with the same instruments 
as that used in the determination of fatty acid titers. The ratio of saturated to unsaturated fatty 
acids (S:U) and weight-average lipid length were calculated as previously described (L. A. 
Royce et al., 2013). 
 
Results and Discussion  
 
Verified mutations in evolved strains 
To identify mutations acquired during the metabolic evolution experiment, we 
sequenced the genomic DNA of ML115, LAR1, and LAR2 using the Illumina platform. We 
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used the breseq pipeline and short-read aligner, Bowtie2, to map reads from each strain to the 
E. coli K-12 MG1655 reference genome and identify sequence variations. A 768 bp insertion 
sequence (IS) was predicted in waaG in the parent strain, but neither of the evolved strains. 
The same mutation in rpoC was predicted in both evolved strains and results in an amino 
acid change from histidine to proline at position 419 in RpoC. Each evolved strain exhibits a 
mutation related to the BasS-BasR two-component signal transduction system. In LAR1, 
basR has a point mutation that results in an amino acid change from aspartic acid to tyrosine 
at position 28 in the protein product. In LAR2, basS has a 27 bp deletion that results in a 9 
amino acid (aa) deletion in BasS. Mutations predicted in both the parent and evolved strains 
were not considered for further analysis. Computationally predicted mutations were verified 
by PCR and Sanger sequencing. 
Genome diff files from the breseq output for the parent and evolved strains were 
submitted as input to the EVA pipeline (Boggess, Jarboe, & Dickerson, 2018) for additional 
analysis. HGVS-style descriptions (den Dunnen et al., 2016) of amino acid variations were 
generated by the EVA pipeline where applicable. Provean scores (Choi, Sims, Murphy, 
Miller, & Chan, 2012), which provide an indication of whether a mutation may be damaging 
(score ≤ -2.5) or tolerated (score > -2.5) and EVA prioritization of mutations are provided in 
Table 3.3. 
EVA analysis also generates a network representation of mutated features and 
downstream biological features that may be influenced by the mutation through gene 
regulation and cellular metabolism (Figure 3.1). However, we find that the latest release of 
RegulonDB, version 9.4 (Gama-Castro et al., 2016), does not include some published 
regulatory activities for the BasR transcription factor, specifically transcription activation of 
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waaH (computationally predicted), eptA, and arnBCADTEF (Froelich, Tran, & Wall, 2006; 
H. Ogasawara, S. Shinohara, K. Yamamoto, & A. Ishihama, 2012). We manually 
supplemented EVA with nine transcription activation links from BasR to each of these genes. 
From this updated visualization, we do not find any immediate relationship among mutations 
that occur in any individual strain. However, the relationship between basS and basR is clear 
in the network and genes in the BasR regulon are candidates for further study as their 
expression may be affected by either mutation in the evolved strains. 
Pathways included in the EVA-generated network include proline degradation and 
proline to cytochrome electron transfer, the QseBC quorum-sensing two-component system, 
which is involved in regulation of flagella biosynthesis, and polymyxin resistance. In 
addition, many genes in the BasR regulon are located in the membrane: putA, eptA, dgkA, 
waaH, qseC, arnCDTEF, and csgDEFG. Some of the genes in the BasR regulon, such as 
qseB, putA, and csgD also encode transcription factors which may alter expression of 
additional genes through transcription regulation. The eptA and waaH genes are particularly 
interesting because of their role in modifying LPS as is the csg operon for its relevance to 
curli assembly and biofilm formation. 
It must also be noted that interactions between RNA polymerase and promoter 
sequences are numerous and not represented in this network, but a query of the RegulonDB 
database identifies 1,606 genes with associated sigma 70 promoters. Because the rpoC 
mutation could affect transcription initiation of a large number genes, additional analysis 
may benefit from a transcriptomic experiment. 
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Table 3.3  EVA annotation and prioritization of mutations in ML115, LAR1, and LAR2. 
Mutations are ordered by position in the genome. IS indicates the introduction of an insertion sequence at the specified position. 
M
L1
15
 
LA
R
1  
LA
R
2 
Position Annotation b-number Mutation HGVS description Provean score EVA priority 
* * * 144,786 yadI b0129 G → T A70A N/A Low 
* * * 1,704,001 ydgJ b1624 A → C Q103P -3.86 High 
* * * 1,873,031 dgcJ b1786 IS R331_S496delinsGCTSV YTKMCREKILVMR -387.40 High 
* * * 1,946,308 yebB b1862 
IS 
G20_V200delinsVLPYLV 
KYQLHQIAGVITSGSLS 
VITVKTSWLQKAGFPFQ 
PSPRYLVLLNVRLINAML 
-451.03 High 
* * * 2,610,245 hyfH b2488 G → A G28S -2.61 High 
*   3,806,607 waaG b3631 
IS 
H154_G374delinsLIKLNL 
NVFKFFLPVFIRTENTVS 
KSQTAVKFIARKMA 
-674.93 High 
 * * 4,186,605 rpoC b3899 A → C H419P -9.35 High 
* * * 4,296,381 intergenic 
(gltP/yjcO) 
(b4077/b4078) +GC  N/A Unassigned 
  * 4,332,397 basS b4112 Δ27 bp A285_G293del -25.51 High 
 *  4,333,869 basR b4113 C → A D28Y -7.76 High 
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Figure 3.1  EVA-generated network. 
Network representation of mutated features that differ in parent strain, ML115, and evolved 
strains LAR1 and LAR2 and biological features related through gene regulation and 
metabolic pathways. Red nodes correspond to mutated features. Node shapes show feature 
type: ovals = genes, diamonds = gene products, triangles = reactions, hexagons = metabolic 
pathways. 
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RpoC, which contains a mutation both evolved strains, encodes the β' subunit of the 
RNA polymerase sigma 70 factor. The RNA polymerase sigma 70 factor is the primary 
sigma factor in E. coli K-12 MG1655 during exponential growth conditions (Jishage, Iwata, 
Ueda, & Ishihama, 1996) and functions to stabilize the open promoter complex during 
promoter melting and transcription initiation (Wigneshweraraj, Burrows, Severinov, & Buck, 
2005). Thus, the mutation in rpoC gene could widely affect gene transcription in the evolved 
strains. Different mutations in rpoC gene were found in other evolutionary studies of acid 
tolerance, and the mutated RpoC (V507L) contributed to increased acid-tolerant phenotype 
(Harden et al., 2015). It is possible that the mutated RpoC (H419P) contributes to the 
increased C8 tolerance observed in the evolved strains through altered expression of genes 
with sigma 70 promoters. 
We also confirmed a mutation in BasR (D28Y) in LAR1, which encodes the 
transcriptional regulator component of BasS-BasR system. The BasS-BasR two-component 
system is one of the two component signal transduction systems in E. coli which senses and 
responds to changes in environmental conditions (Hiroshi Ogasawara, Shota Shinohara, 
Kaneyoshi Yamamoto, & Akira Ishihama, 2012). In an evolutionary study of n-butanol 
tolerance, overexpression of basS was found to increase tolerance (Reyes, Almario, Winkler, 
Orozco, & Kao, 2012). Coincidentally, we found a 27 deletion in basS in LAR2, which 
encodes sensory histidine kinase of the BasS-BasR system. 
The 768 bp insertion (InsB-5, InsA-5, and InsAB-5) found in waaG in the parent 
strain, ML115, is predicted to interrupt the expression of waaG and potentially alter the 
expression level of downstream genes in its operon: waaP, waaS, waaS, waaO, waaJ, waaY, 
waaZ, and waaU (Figure 3.2). In the evolved strains, this insertion was not detected, 
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suggesting that the insertion sequence had moved and waaG had been restored. WaaG is a 
lipopolysaccharide (LPS) glucosyltransferase I enzyme which adds the first glucose of the 
outer core of LPS. 
 
Figure 3.2  An insertion sequence interrupts waaG in ML115. 
The insertion sequence, insAB-5, is found in the parent strain, ML115, and potentially affects 
transcription of other genes downstream of waaG. 
 
Colony morphology of parent and evolved strains 
The deletion of waaG gene has been shown to result in a truncated LPS core, loss of 
flagella pili (Parker et al., 1992), enhanced cell surface hydrophobicity, increased outer 
membrane permeability, and decreased ability of biofilm formation (Wang, Wang, Ren, Li, 
& Wang, 2015). The deletion of waaGPBI leads to a mucoid colony morphology (Parker et 
al., 1992), which is consistent with the morphological characteristics of ML115 compared to 
LAR1 on LB plates (Figure 3.3). Transmission electron microscopy images also reveal a lack 
of flagella in ML115 when waaG is non-functional and presence of flagella in LAR1 in 
which waaG is restored (Figure 3.4). 
 
The order in which mutations were acquired during the metabolic evolution experiment 
PCR experiments were performed on the parent strain, LAR1, and intermediate 
samples corresponding to the serial transfers performed in the original metabolic evolution 
waaG waaQwaaPwaaSwaaBwaaOwaaJwaaYwaaZwaaU
3,805,943 3,807,067
3,806,607
insAB-5
insA-5insB-5
1,978,518 1,979,215
insA-5p
waaQpwaaYpwaaZpwaaUp
768 bp IS
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experiment to detect the presence of the variant genomic sequence observed in the evolved 
strain. PCR fragments for each sample are shown in Figure 3.5. We find that waaG is 
repaired early in the experiment as can be seen by the decrease in fragment size which 
corresponds to the loss of the insertion sequence. The rpoC mutation is acquired in the 
middle of the metabolic evolution experiment, and the basR mutation is not detected until the 
end of the experiment. As LAR1 and LAR2 were not evolved independently, we may deduce 
that the basS mutation in LAR2 is similarly not acquired until the end of the experiment. 
 
Growth ability of reconstructed strains in C8 challenge experiments 
In order to identify mutations that contribute to C8 tolerance, we systematically 
introduced mutations into the parent strain, ML115, in the order they were acquired in the 
metabolic evolution experiment. We hypothesized that if a mutation was critical to C8 
tolerance, its addition to ML115 would improve the growth rate in a C8 challenge 
experiment. In addition, the combined effect of the basR and basS mutations examined both 
with and without the repair of waaG. 
None of the rpoC, basS, or basR mutations showed an improvement in C8 tolerance 
when introduced into ML115 individually that would account for the tolerance phenotype of 
LAR1 (Table 3.4). Removing the insertion sequence present in waaG in the parent strain 
increased the growth rate in 10 mM C8 compared to ML115 with the non-functional waaG 
gene (Figure 3.7A and B). The increase in growth ability observed in LAR1 vs ML115 
(Figure 3.7A and E), however cannot be attributed to the restoration of waaG alone. The 
incorporation of the rpoC mutation after waaG is repaired further improves C8 tolerance 
(Figure 3.7C). Reconstructing the basR mutation after the waaG repair and rpoC mutation 
are incorporated does not further improve tolerance (Figure 3.7D).  
 77 
 
 
  
Figure 3.3  Morphological characteristic of ML115 and LAR1. 
ML115 is shown on the left and LAR1 is shown on the right on LB agar plates at 37°C. 
 
 
Figure 3.4  Transmission electron microcopy images of ML115 and LAR1. 
ML115 is shown on the left and LAR1 is shown on the right. Flagella are noticeably absent 
in ML115 and restored in LAR1. 
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Figure 3.5  PCR experiments to determine the order of mutations. 
PCR experiments for intermediate samples reveal the order in which mutations were 
acquired during the metabolic evolution experiment. Fragment sizes are labeled on the 
righthand ladder (in bp). 
 
Figure 3.6  Extracellular polymetric substance analysis for ML115, LAR1, and reconstructed 
strains. 
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Interruption of waaG expression has been shown to result in a truncated LPS, 
decreased expression of major outer membrane proteins, and hypersensitivity to hydrophobic 
antibiotics (Parker et al., 1992; Yethon, Vinogradov, Perry, & Whitfield, 2000). In our 
previous study, the specific grow rate of MG1655 was greater than 0.5 h-1 in MOPS with 
2.0% (w/v) glucose and 10 mM C8 (L. A. Royce et al., 2013), while the ML115 could barely 
grow under the same condition. Furthermore, octanoic acid is a hydrophobic chemical. Based 
on these observations, we believed the waaG insertion to cause octanoic acid hypersensitivity 
in the parent strain, ML115. 
Interestingly, when measuring extracellular polymetric substances, we find an 
abundance of polysaccharides present in ML115 and a sharp decrease when waaG is restored 
(Figure 3.6). Many other genes are required to synthesize LPS and it is possible that the 
organism is compensating for the damaged waaG by overexpressing other LPS genes. The 
addition of other mutations does not greatly affect the abundance of polysaccharides. The 
protein content of the free extracellular polymetric substance was only slightly lower as the 
LAR1 genotype was reconstructed in the parent strain.  
The repair of rpoC in LAR1 significantly decreased the growth rate in 10 mM C8 
compared to the LAR1 strain (data not shown) and introducing the rpoC mutation into 
ML115 with a repaired waaG gene further increased C8 tolerance (Figure 3.7C). This 
indicates that the rpoC mutation is important for the C8 tolerance phenotype of evolved 
strain. As previously mentioned, the rpoC mutation could widely alter genes expression 
level. 
Because of the rate of mutations in RNA polymerase genes in evolution experiments, 
there has been interest in investigating the relevance of these variations to fitness and their 
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mechanisms (Conrad et al., 2010). For several mutations in rpoB and rpoC genes, Conrad et 
al. found improved growth in minimal media and slower growth in rich media. They also 
observed a decrease in the open complex longevity at the promoter and an increase in the 
transcript elongation rate. Transcriptomic analysis of ML115 and LAR1 is needed to uncover 
what global effects the rpoC mutation exerts on the evolved strain and which genes with 
altered expression might influence C8 tolerance. 
The repair of basR in LAR1 strain and introduction in ML115 strain did not change 
the growth ability in the 10 mM C8 tolerance test (Figure 3.7D), demonstrating that the basR 
mutation alone is not able to increase the C8 tolerance. The introduction of the basS mutation 
from LAR2 into LAR1 did not further enhance the C8 tolerance phenotype. Similarly, the 
introduction of the basS mutation into ML115 did not affect tolerance at 10 mM C8 (Table 
3.4). As the basS and basR mutations were acquired near the end of the evolution 
experiment, which corresponded to a concentration of 30 mM C8, repeating the growth 
experiment at a higher concentration may reveal some yet observed contribution to tolerance 
from these mutations. 
 
The waaG, basS and basR mutations affect the cell membrane 
Previous studies identified membrane damage as a key mechanism of microbial 
inhibition when applying exogenous octanoic acid challenge to E. coli strains or during fatty 
acid production (Jarboe et al., 2013; Lennen & Pfleger, 2013; L. A. Royce et al., 2013; L. A. 
Royce et al., 2015; Sherkhanov et al., 2014), but the introduction of basS and basR mutations 
in ML115 did not show improved tolerance at 10 mM C8. However, membrane 
characterization of the reconstructed strains revealed that these mutations improve cell 
membrane integrity. 
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Figure 3.7  Growth ability of ML115, LAR1, and reconstructed strains in the order that mutations were acquired. 
Strains were grown in MOPS media with 2.0% (w/v) glucose with 0 and 10 mM octanoic acid at 37°C. A. The parent strain, ML115; 
B. ML115 with waaG repaired; C. ML115 with repaired waaG and the rpoC mutation; D. ML115 with repaired waaG, the rpoC 
mutation, and the basR mutation; E. The evolved strain LAR1. Values are the average of three biological replicates. Coloring is 
consistent for these strains throughout all figures.  
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Table 3.4  Growth ability of ML115, LAR1, and reconstructed strains. 
The top section of the table has data for the evolved strain, LAR1, the parent strain, ML115, and reconstructed strains with mutations 
in the order they were acquired in the metabolic evolution experiment. The bottom section of the table shows other reconstructed 
strains used to analyze independent and combined contributions of mutations to octanoic acid tolerance. For each strain, specific 
growth rate (GR), time at which log phase occurs, the inflection OD, and the 24 hour OD are provided. Coloring is consistent for the 
strains in all figures presented in this document. Inflection OD is defined as the value of OD550 and the first time point recorded 
corresponding to stationary phase. 
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Specific GR 
Log 
Phase Inflection OD 24 h OD Specific GR 
Log 
Phase Inflection OD 24 h OD 
LAR1 * * *  0.56±0.00 3~7 h 2.53±0.07 (8 h) 3.01±0.04 0.56±0.00 4~8 h 2.34±0.04 (9 h) 2.20±0.07 
ML115     0.60±0.01 3~6 h 2.04±0.07 (7 h) 3.17±0.07 0.15±0.00 ND ND 0.29±0.01 
ML115+waaGInD *    0.53±0.01 3~7 h 1.99±0.02 (8 h) 2.87±0.17 0.39±0.01 6~11 h 1.66±0.03 (12 h) 1.57±0.03 
ML115+waaGInD+rpoC* * *   0.57±0.01 3~7 h 2.47±0.00 (8) 3.07±0.11 0.55±0.02 4~8 h 2.31±0.06 (9 h) 2.20±0.02 
ML115+waaGInD+rpoC*+basR* * * *  0.57±0.00 3~7 h 2.55±0.03 (8 h) 2.98±0.04 0.57±0.01 4~8 h 2.20±0.03 (9 h) 2.13±0.01 
ML115+rpoC*  *   0.65±0.01 3~6 h 1.95±0.04 (7 h) 3.00±0.02 0.23±0.01 ND ND 0.38±0.02 
ML115+basR*   *  0.60±0.00 3~6 h 1.90±0.02 (7 h) 2.61±0.02 0.15±0.00 ND ND 0.28±0.01 
ML115+basS*    * 0.60±0.01 3~6 h 1.96±0.04 (7 h) 2.74±0.02 0.16±0.00 ND ND 0.31±0.01 
ML115+waaGInD+basR* *  *  0.45±0.01 4~8 h 2.39±0.02 (9 h) 3.00±0.10 0.35±0.01 6~11 h 1.92±0.02 (12 h) 1.57±0.07 
ML115+waaGInD+basS* *   * 0.52±0.01 3~7 h 2.25±0.03 (8 h) 2.95±0.12 0.35±0.01 5~9 h 1.56±0.08 (10 h) 1.30±0.08 
ML115+rpoC*+basR*  * *  0.67±0.00 2~5 h 1.98±0.01 (6 h) 2.88±0.05 0.16±0.00 ND ND 0.17±0.02 
ML115+basR*+basS*   * * 0.54±0.00 3~7 h 1.94±0.04 (8 h) 2.34±0.09 0.20±0.01 ND ND 0.21±0.01 
ML115+waaGInD+basR*+basS* *  * * 0.47±0.01 3~8 h 2.44±0.03 (9 h) 2.98±0.04 0.39±0.00 4~10 h 1.76±0.02 (11 h) 1.53±0.03 
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Membrane fluidity can be measured as a fluorescence polarization, and the increased 
membrane polarization corresponds to decreased fluidity and an increase in membrane 
rigidity. 
After being treated with 10 mM C8 for 1 hour, the ML115+basR* and ML115+basS* 
strains showed significantly higher membrane polarization than ML115 and ML115+rpoC* 
strains (Figure 3.8B), showing that basS and basR mutations improved cell membrane 
rigidity. There is no significant difference in cell membrane rigidity between LAR1 and 
LAR1+rpoC after treatment which showed that the rpoC mutation in LAR1 is not 
responsible for the increased cell membrane rigidity phenotype. 
Directly comparing strains with and without a 10 mM C8 treatment revealed that all 
strains except ML115 and ML115+rpoC* have significantly higher membrane polarization, 
suggesting they can alter the cell membrane by sensing and responding to the altered 
environmental condition. Additionally, the ML115+basR*, ML115+basS* and LAR1+rpoC 
strains reached a similar membrane polarization level as LAR1 after treatment. We 
hypothesize that the basS and basR mutations are the key contribution to improve cell 
membrane rigidity in the evolved strains. 
Examining reconstructed strains that illustrate the order of acquired mutations, we 
observe an increase in cell membrane rigidity at 10 mM C8 with the addition of each 
mutation (Figure 3.8A). There may exist some synergistic effect between the waaG repair 
and rpoC mutation. A further increase to cell membrane polarization is seen with the addition 
of the basR mutation at 10 mM C8. 
Membrane leakage is another key factor of cell membrane damage. We used flow 
cytometry to separate and quantify SYTOX-permeable and SYOX-impermeable cells, where 
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permeability of SYTOX indicates a damaged cell membrane. Without exogenous 10 mM C8 
challenge, only about 5% of ML115, ML115+rpoC*, ML115+basR*, and ML115+basS* 
strain population became SYTOX-permeable (Figure 3.9A). After a C8 challenge for 1 hour, 
the permeable strain population of ML115 and ML115+rpoC* increased to 17.57±2.79% and 
11.07±1.44%, while the permeable strain population of ML115+basR* and ML115+basS* 
decreased to 3.2±0.37% and 2.93±0.45% (Figure 3.9A). 
These results show that restoring waaG is primarily responsible for preventing cell 
membrane leakage, the rpoC mutation partially restores cell membrane leakage, and the basS 
and basR mutations help reduce cells membrane leakage. Additionally, the SYTOX-
permeable strain population of ML115+basR* and ML115+basS* significantly decreased 
after C8 challenge (Figure 3.9B), showing the altered cell membrane for strains with basS or 
basR mutations has increased the resistance to exogenous 10 mM C8 challenge compared to 
no C8 challenge. The SYTOX-permeable strain population of LAR1 and LAR1+rpoC were 
2.17% and 2.7% without C8 treatment (Figure 3.9B). After treated with 10 mM C8 for 1 
hour, the permeable strain population of LAR1 decreased to 1.93±0.45%, while it increased 
to 4.37±0.57% when the rpoC mutation repaired in LAR1 (Figure 3.9B). 
This decreased resistance is consistent with the partially restores cell membrane leakage in 
ML115+rpoC*. 
Strains that reconstruct the order of acquired mutations show that repairing waaG 
reduces the percent of SYTOX-permeable cells drastically. The next mutation, in rpoC, 
partially restores cell membrane leakage, and finally, the basR mutation again alleviates cell 
membrane leakage (Figure 3.9A). 
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Measurements of the membrane fluidity and membrane leakage help to understand 
how each mutation alter the cell membrane properties for increasing resistance to C8 
tolerance and increasing fatty acid production. These results show that the rpoC mutation, 
while a factor of increasing C8 tolerance, does not contribute to increased membrane rigidity 
and partially restores cell membrane leakage. The basS and basR mutations can separately 
increase the cell membrane rigidity and prevent cell membrane leakage, but do not contribute 
to C8 tolerance phenotype at 10 mM C8. 
Additionally, cell surface hydrophobicity was measured for individual mutations and 
strains that reconstruct the order of acquired mutations. The evolved strain, LAR1 exhibits a 
higher percentage of hydrophobicity than the parent strain, ML115 for which no individual 
mutation can account. The repair of waaG decreases the percent hydrophobicity and the basS 
mutation increases the percent hydrophobicity in 10 mM C8 compared to the control 
condition when each are introduced individually into ML115 (Figure 3.10B). However, when 
examining reconstructed strains with multiple mutations, an increase in percent 
hydrophobicity is seen with the addition of the rpoC and then basR mutations, suggesting a 
synergistic effect. The incorporation of the variant basR can achieve the percent 
hydrophobicity of the LAR1 strain. 
Finally, we examine the effect of each mutation on membrane lipid composition as 
well as the cumulative effects of mutations in the order they were acquired. Interestingly, we 
find that different mutations result in different lipid compositions. For example, the rpoC 
mutation leads to increased mono-unsaturated fatty acids C16:1 and C18:1 and decreasd 
saturated fatty acid C16 while the restoration of waaG has the opposite effect (Figure 3.11A 
and B). The effects were similar with and without the 30 mM exogenous C8 treatment, but 
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with an overall decrease in C14:0 and C17cyc. Examining mutations in the order they were 
acquired shows that mutations subsequent to waaG increased C18:1 and decreased C16:0 
(Figure 3.11C and D). 
A 
 
B 
  
Figure 3.8  Membrane polarization. 
Membrane polarization of reconstructed strains at mid-log phase (OD ≈ 1) with 10 mM C8 
challenge. A. membrane polarization of strains in the order that mutations were acquired in 
the metabolic evolution experiment; B. membrane polarization for the parent strain, evolved 
strain, and strains with individual mutations introduced into ML115. Values are the average 
of three biological replicates, each biological replicate has four technical replicates and 
error bars show standard deviation. 
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Figure 3.9  Membrane leakage 
Membrane leakage of reconstructed strains and at mid-log phase (OD ≈ 1) with 10 mM C8 
challenge. A. membrane leakage of strains that recreate the order in which mutations were 
acquired in the evolution experiment; B. membrane leakage of the parent strain, evolved 
strain LAR1, and individual mutations introduced into the parent strain. Values are the 
average of three biological replicates, and error bars show standard deviation. 
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A 
 
B 
 
Figure 3.10  Percent of hydrophobicity. 
Percent of hydrophobicity for parent strain, evolved strain, and other reconstructed strains. 
A. reconstructed strains that recreate the order in which mutations were acquired in the 
metabolic evolution experiment; B. reconstructed strains illustrating individual contribution 
of mutations. Values are the average of two biological replicates and two technical replicates 
and error bars show standard deviation. 
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D
 
Figure 3.11  Membrane lipid composition. 
Membrane lipid composition for reconstructed strains at 0 (A and C) and 30 mM (B and D) C8. Values are the averages of three 
biological replicates and error bars show standard deviation. A and B show the effects of individual mutations on membrane lipid 
composition and C and D show the cumulative effects of mutations acquired in the metabolic evolution experiment. 
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The waaG and rpoC mutations improve fatty acid titer 
In addition to improving tolerance to octanoic acid, the repair of waaG demonstrates 
some improvement to fatty acid titer and when the introduction of the rpoC mutation is 
incorporated, titer matching that of LAR1 at 24 and 72 hours is observed (Figure 3.12). We 
have shown that a non-functional waaG decreases C8 tolerance and alters membrane 
properties. The mutation in rpoC, the β’ subunit of RNA polymerase sigma 70 subunit, is 
anticipated to alter expression of genes with sigma 70-associated promoters in exponential 
growth conditions. We previously described the mutation as predicted to be damaging in 
EVA analysis because the genomic variation is not found among published genomic 
sequences, however, as rpoC plays a critical role in transcription initiation, it is likely that its 
behavior is modified, which in turn, could achieve a wide range of phenotypic effects by 
perturbing global transcription. Indeed, mutations in the primary RNA polymerase genes 
have been found in several adaptive evolution experiments (Applebee, Herrgård, & Palsson, 
2008; Jin & Gross, 1988; Klein-Marcuschamer, Santos, Yu, & Stephanopoulos, 2009; Trinh, 
Langelier, Archambault, & Coulombe, 2006; Zhou & Jin, 1998). In addition to increasing the 
specific growth rate in the C8 challenge condition, the rpoC mutation appears to be a critical 
mutation for rewiring global transcription to support increased fatty acid titer in LAR1. 
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Figure 3.12  Fatty acid titer measured over time. 
Fatty acid titers for ML115, LAR1, and reconstructed strains at 6, 12, 24, and 72 hours. 
Values are the average of three biological replicates and error bars represent standard 
deviation. 
 
Summary 
In this study we reverse engineered E. coli strains LAR1 and LAR2 which were 
evolved for improved octanoic acid tolerance. Through whole genome sequencing, we 
identified mutations in rpoC in both evolved strains and basR and basS separately in each 
strain. We also discovered a key mutation in the parent strain, ML115, which was an 
insertion sequence in the waaG gene that was lost during the experiment. Through PCR 
analysis of intermediate samples, we showed that waaG was repaired early in the evolution 
experiment, followed by the rpoC mutation, and finally the basS and basR mutations in 
LAR1 and LAR2, respectively. We predict each of these mutations to be damaging based on 
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Provean analysis which considers conservation at the mutation site among published gene 
products with sequence similarity. 
Both individual and collections of mutations were repaired in the evolved strain and 
introduced in the parent strain in order to characterize their contribution to phenotype. We 
show that non-functional waaG is detrimental to tolerance and affects membrane properties. 
A drastic reduction in membrane leakage is observed after waaG is repaired. The basS and 
basR mutations alter the cell membrane by increasing percent hydrophobicity and membrane 
polarization. Finally, the rpoC mutation contributes both to tolerance and increases fatty acid 
titer. 
The independent mutations in basS and basR may affect the BasS-BasR two-
component signal transduction system and alter transcription of genes in the BasR regulon. 
Using the gene regulatory and metabolic network generated by EVA, we identified candidate 
genes in the BasR regulon waaH and eptA for further study based on their function in 
modifying LPS. The csg operon was also of interest for its role in curli assembly and biofilm 
formation. Modification of these functions may have a similar effect on the evolved strain 
phenotype as the repair of waaG which is also involved in LPS modification, surface 
organelle biosynthesis, and biofilm formation. 
We hypothesize that the rpoC mutation alters global transcription in the evolved 
strains. We searched promoter sequences in the publicly available database, RegulonDB, and 
found 1,606 genes with associated sigma 70 promoters. Due to this large number of genes 
and sigma 70 being the primary sigma factor during exponential growth, a forthcoming 
RNA-seq study will compare the transcriptomes of ML115 and LAR1 and identify genes 
with altered expression that contribute to the tolerance phenotype. 
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Abstract 
Reverse engineering of strains obtained through metabolic evolution remains a 
significant challenge. Whole genome analysis is crucial for identifying mutations that are 
responsible for altered phenotype. These mutations can be introduced into ancestral strains 
and repaired in evolved strains to determine their relevance to improved fitness. In some 
cases, however, mutations arise in regulators and to understand the biological mechanisms 
responsible for phenotype, regulated genes must be studied. In our previous work, we 
identify mutations in a transcription factor and the β’ subunit of RNA polymerase (rpoC) in 
Escherichia coli evolved for improved octanoic acid tolerance (Boggess, Jarboe, & 
Dickerson, 2018). Here, we present an RNA-seq study to support reverse engineering efforts 
and integrate our transcriptomic analysis findings with gene regulatory and metabolic 
pathway data. We identify differentially expressed genes regulated by mutated features as 
candidate genes, construct gene knockout strains, and test for altered growth rate with 
exogenous octanoic acid. 
Introduction 
Metabolic evolution been previously used as a successful strategy for developing 
strains of Escherichia coli with increased improved to octanoic acid and increased short-
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chain fatty acid production (C8) (Royce et al., 2015). These strains have been characterized 
has having an altered membrane with increased polarization, decreased leakage, longer 
average lipid length, and an altered saturated to unsaturated fatty acid ratio. The evolved 
strains also have restored flagella, a decrease in extracellular polymetric substances and an 
increase in percentage hydrophobicity (Chen, Boggess, Dickerson, & Jarboe, 2018). Our 
previous work in reverse engineering the evolved strains LAR1 and LAR2 involved whole 
genome sequencing and mutation analysis. We identified an insertion sequence that leads to a 
non-functional waaG in the parent strain, ML115, a point mutation in rpoC in both evolved 
strains, a point mutation in basR in LAR1, and a 27 base pair (bp) deletion in basS in LAR2 
(Chen et al., 2018). 
Our previous work identified the restoration of waaG as a large contributor to the 
evolved strain phenotype, however this mutation does not reproduce the fatty acid titer and 
growth ability observed in LAR1. The mutations involving RpoC, the β’ subunit of RNA 
polymerase, and BasS-R, a two-component signal transduction system are believed to affect 
expression of other genes through transcription regulation rather than directly contribute to 
phenotype. The variant β’ subunit may affect global gene expression in the evolved strains. 
The BasR regulon involves 22 genes, however some of these genes encode transcription 
factors and expression for additional downstream genes in the regulatory network may be 
affected by the mutant BasR. 
In order to continue our work on reverse engineering LAR1, we must investigate the 
effects of mutations in regulators. In this work, we demonstrate the added value of omics 
experiments for reverse engineering microbial strains produced in metabolic evolution 
experiments, particularly when variant global regulators and transcription factors are found in 
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evolved strains. We also integrate transcriptomic data into the gene regulatory and metabolic 
network we hypothesize are affected by genomic mutations (Boggess et al., 2018). We 
performed RNA-seq experiments for ML115 and LAR1 for control and fatty acid production 
conditions. We analyzed transcriptomic data to find genes that are differentially expressed in 
the parent and evolved strain. Incorporating our prior knowledge about the genotypes of 
these strains and integrating transcriptomic data with gene regulatory and metabolic pathway 
data, we identified candidate genes to test for relevance to improved phenotype. 
 
Methods 
 
Bacterial strains, plasmids, and media 
Plasmids, strains from the octanoic acid evolution experiment, and reconstructed 
strains from this study are described in Error! Reference source not found.. E. coli DH5ɑ 
was used as a cloning strain, while the parent strain, ML115 and the evolved strain LAR1 
were used in genome modification procedures. All strains were grown overnight at 37ºC with 
250 rpm orbital shaking in 25 mL of MOPS minimal media (Wilmes-Riesenberg & Wanner, 
1992) with 2% glucose and chloramphenicol (35 µg/mL, if needed) in 250 mL baffled flasks. 
The overnight cultures were diluted to 0.05 optical density (OD) at 550 nm (OD550) for the 
octanoic acid (C8) tolerance test or diluted to OD550 = 0.1 for testing membrane leakage, 
membrane fluidity, cell hydrophobicity, and cell membrane composition. Transformants 
were grown in LB media at 37ºC or 30ºC, with chloramphenicol (35 mg/L), ampicillin (100 
mg/L), kanamycin (50 mg/L), or spectinomycin (50 mg/L) as needed. 
 102 
 
Table 4.1  Strains and plasmids used in this study. 
Plasmids or strains Genotype or description Reference 
Plasmids 
  
pJMY-EEI82564 pTrc-EEI82564 thioesterase (TE10) 
from Anaerococcus tetradius, AmpR 
(Royce et al., 2015) 
pJMY-Empty pTrcHis B without the thioesterase 
(TE10), AmpR 
This study 
Strains 
  
ML115 MG1655 (∆fabD, ∆poxB, ∆ackA-pta: 
cmR) 
(Li, Zhang, 
Agrawal, & San, 
2012) 
LAR1 ML115 evolved for C8 tolerance, CmR (Royce et al., 2015) 
LAR2 ML115 evolved for C8 tolerance, CmR (Royce et al., 2015) 
ML115+pJMY-Empty ML115 with “empty” plasmid This study 
ML115+pJMY-EEI82564 ML115 with thioesterase for SCFA 
production 
This study 
LAR1+pJMY-Empty LAR1 with “empty” plasmid This study 
LAR1+pJMY-EEI82564 LAR1 with thioesterase for SCFA 
production 
This study 
ML115+waaGInD ML115 with insertion sequence 
removed from waaG  
This study 
ML115+waaGInD+rpoC* ML115 with repaired waaG and rpoC 
mutation found in LAR1 and LAR2 
This study 
ML115+waaGInD+∆bssS ML115 with waaG repair and ∆bssS This study 
 
Growth analysis 
Octanoic acid tolerance was determined by measuring OD550 every hour. Overnight 
seed cultures were inoculated into 250 mL baffled flasks, which contained 25 mL MOPS 
with 2.0% (w/v) dextrose and 10 mM octanoic acid (1.44 g/L) with an initial media pH of 7.0 
and an initial OD550 of 0.05. The control groups used the same culture without the addition of 
octanoic acid. The flasks were incubated in a rotary shaker at 200 rpm and 37ºC. Cultures 
were taken and measured at OD550 every hour. 
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RNA Isolation 
Total RNA was isolated from saved cell pellets sampled at 6, 12, and 24 hours using 
RNeasy mini kit (Qiagen, Valencia, CA). Genomic DNA contamination was removed by 
Turbo DNA-free kit (Life Technologies, Carlsbad, CA), followed by the verification of total 
RNA using Agilent 2100 Bioanalyzer and RNA 600 Nano total RNA kit (Agilent, Santa 
Clara, CA). Next, ribosomal RNA (rRNA) was removed by Ribo-Zero (Bacteria) Magnetic 
kit (Illumina, San Diego, CA). Messenger RNA (mRNA) and other small RNA were purified 
and concentrated by Rneasy MinElute Cleanup kit (Qiagen, Valencia, CA). Agilent 2100 
Bioanalyzer and RNA 6000 Pico mRNA kit (Agilent, Santa Clara, CA) were used to verify 
that the sample contained mRNA and other small RNA, but no rRNA. All procedures 
followed the manufacturers' user guide. 
 
Fermentation for fatty acid production 
The fatty acid production strains harboring the pJMY-EEI82564 plasmid by 
electroporation were grown on LB plates with ampicillin (100 mg/L) and incubated at 30ºC 
overnight. Individual colonies were precultured in 10 mL LB media with ampicillin (100 
mg/L) in 250 mL flasks at 30ºC, 250 rpm with orbital shaking overnight. Seed cultures were 
then inoculated into 250 mL baffled flasks containing 50 mL of LB media with 1.5% 
dextrose, ampicillin (100 mg/L), and isopropyl-β-D-thiogalactopyranoside (IPTG) (1.0 mM) 
at an initial OD550 of 0.1. The flasks were incubated in a rotary shaker at 200 rpm and 30ºC, 
the culture samples were saved for testing fatty acid titer at 6, 12, 24, and 48 hours.  
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RNA-seq and short read analysis 
For the transcriptomic analysis, RNA samples from the 6, 12, and 24 hour time points 
were obtained. These three time points were chosen to represent the lag phase, mid-log 
phase, and the stationary phase. After 24 hours, the OD550 value, the fatty acid titer, and the 
glucose concentration of the four strains did not vary significantly. The transcriptomic 
experiment performed was designed as a multi-factor experiment with three factor levels: 
strain, plasmid, and time. The two strains used in the experiment were the parent strain, 
ML115, and the evolved strain, LAR1. Plasmids were introduced into the strains to create a 
short chain fatty acid production condition (pJMY-EEI82564) and a control condition 
(pJMY-Empty). The plasmid pJMY-EEI82564 contains an acyl-acyl carrier protein 
thioesterase from Anaerococcus tetradius and an pJMY-Empty contains the same genetic 
material, but without the thioesterase gene. The multi-factor experiment had twelve 
combined factor levels with four biological replicates each for a total of forty-eight samples. 
Single-end, directional RNA-Seq was performed by the Iowa State University DNA 
facility using the Illumina HiSeq 3000 platform with reads 100 base pairs (bp) in length. 
Reference-based assembly was performed using Rockhopper2 (version 2.0.3), which is 
designed specifically for bacterial systems (McClure et al., 2013). We created a reference 
transcriptome was corresponding to pJMY-EEI82564 that contained sequences of genes on 
the plasmid. Both de novo assembly and alignment to E. coli K-12 MG1655 (version 
U00096.3) (Blattner et al., 1997; Hayashi et al., 2006) reference transcriptome and pJMY-
EEI82564 transcriptome were performed, which represented a combined 4,321 transcripts. 
Assembled RNA transcripts were used to further validate previously predicted genomic 
mutations. 
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Raw read counts from the Rockhopper2 assembly were analyzed with DESeq2 
version 1.20.0 (Love, Huber, & Anders, 2014), a statistical package for differential 
expression analysis in R version 3.5.0.1 (R Core Team, 2018). DESeq2 was used to 
normalize raw count data and to test for differential expression between conditions and 
calculate pairwise log2 fold change (LFC). Differential expression analysis was performed in 
a pair-wise manner for strain contrasts at each time point and with each plasmid treatment. 
Differentially expressed genes were those with False Discovery Rate (FDR) adjusted p-value 
< 0.05. 
Annotations from EcoCyc (Keseler et al., 2017) and RegulonDB (Gama-Castro et al., 
2016) were used to identify genes with promoters associated with sigma factor 70 or 
belonging to the BasS-BasR regulon. Gene Ontology (GO) enrichment was performed to 
identify trends in gene function and localization annotations (Gene Ontology Consortium 
validation date 12/21/2015) (Ashburner et al., 2000; The Gene Ontology Consortium, 2017). 
Gene lists were analyzed for overrepresented GO terms in the biological process, cellular 
component, and molecular function ontologies using BiNGO and a significance level of FDR 
corrected p-value < 0.05 (Maere, Heymans, & Kuiper, 2005). 
E. coli Variant Analysis (EVA) software (Boggess et al., 2018) was used to generate 
a gene regulatory and metabolic network that reflected mutated features and downstream 
biological elements. Onto the network, we applied fold change data for strain contrasts to 
visualize altered transcript abundance for genes in the BasR regulon. We additionally 
modified EVA for use with candidate gene lists. Given a list of genes as input, we generated 
a gene regulatory and metabolic network to find potential interactions among perturbed 
genes. 
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Results and discussion 
 
Fatty acid fermentation for ML115 and LAR1 with pJMY-EEI82564 or pJMY-Empty 
We first compared the cell growth ability during short-chain fatty acid fermentation 
of E. coli ML115 and LAR1 with pJMY-EEI82564 and pJMY-Empty (Figure 4.1A). LAR1 
with pJMY-EEI82564 reached the highest OD550 = 3.195 at 24 hours, then had a slightly 
decrease to OD550 = 2.828 at 48 h, finally increased to OD550 = 2.94 at 72 hours. ML115 with 
pJMY-EEI82564 reached the highest OD550 = 1.405 at 12 hours, then decreased to OD550 = 
1.035 at 36 hours, finally increased to OD550 = 1.325 at 72 hours. LAR1 and ML115 with 
pJMY-Empty reached stationary phase (OD550 = 1.808 and 2.09) at 12 hours, then slight 
increased to final OD550=2.218 and 2.475.  The LAR1 strain with the pJMY-EEI82546 
plasmid had the highest cell growth ability, even higher than LAR1 with the pJMY-Empty 
plasmid, demonstrating LAR1’s improved growth rate when under SCFA production 
conditions.  
From Figure 4.1Error! Reference source not found.B, we observed that the highest 
fatty acid titer of LAR1 with pJMY-EEI82564 could achieve 420.75 mg/L, which was 3-fold 
higher than that of ML115 with pJMY+EEI82564 (133.3 mg/L). The fatty acid titer of LAR1 
and ML115 with pJMY-Empty was about 35 mg/L. The strains with pJMY-EEI82564 
majorly produced free fatty acids (C4, C6, C8:0, C8:1, C10:0, C10:1, C12:1, C12:0, C14:1, 
C14:0, C16:1, C16:0, C18:1, and C18:0) during exponential phase, the C8 and C16 were the 
primary components (Figure 4.1E). The strains with pJMY-Empty majorly produced free 
fatty acids (C14:0, C16:1, C16:0, C18:1, and C18:0) during log phase (6 to 24 hours), the 
C16:0 and C18:0 were the primary components (Figure 4.1E).  
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LAR1 and ML115 strains with pJMY-EEI82564 consumed glucose primarily during 
the log phase (6 to 24 hours), and the glucose consumption rates were 0.35 g/L/h and 0.14 
g/L/h, respectively (Figure 4.1C). In contrast, LAR1 and ML115 strains with pJMY-Empty 
consumed the most glucose during the lag and log phases (0 to 24 hours), the glucose 
consumption rate is 0.107 g/L/h and 0.165 g/L/h, respectively. After 24 hours, the glucose 
consumption ended for all four strains. 
We also tested the pH of the fermentation media at different time points for all the 
strains (Figure 4.1D). Surprisingly, LAR1 with pJMY-EEI82564 was able to maintain a pH 
above 5.385, which had the highest short-chain fatty acid titer. The pH of the fermentation 
media of LAR1 with pJMY-Empty, LAR1 and ML115 with pJMY-EEI82564 was below 
4.85 at 72 hours. When the LAR1 produced a large number of short-chain fatty acids, the 
LAR1 strain demonstrated a strategy to maintain the pH of media. 
 
Identifying the rpoC mutation effect among differentially expressed genes 
Differentially expressed genes were investigated for relation to the rpoC mutation by 
examining if they exhibited a consistent fold. We hypothesized that the transcriptomic signal 
caused by the rpoC mutation may be present under all time and plasmid conditions in strain 
contrasts. To search for genes affected by the rpoC mutation, we identified genes that exhibit 
a statistically significant and either consistently positive or negative fold change across all 
strain contrasts. Fifty-two genes had lower transcript abundance and sixty-five genes had 
higher transcript abundance in LAR1 versus ML115 for all time points and plasmid 
conditions. These sets of genes were filtered based on if they had a promoter that is 
associated with sigma factor 70, the primary sigma factor in E. coli K-12 MG1655 during 
exponential growth conditions (Jishage, Iwata, Ueda, & Ishihama, 1996). 
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Figure 4.1  Strain characteristics during fatty acid fermentation. 
A) The growth ability; B) Total fatty acid titer; C) Glucose concentration; D) pH of the 
media; E) Relative fatty acid distribution, by weight. Values are the average of four 
biological replicates, and error bars indicate standard deviation. Fermentation was 
performed with LB + 1.5% glucose, ampicillin (100 mg/L), and 1 mM IPTG at 30ºC. 
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Eighteen downregulated and twenty upregulated genes were selected (Table 3.2). Similar 
filters were applied for other sigma factors and the alarmone, ppGpp (guanosine 
tetraphosphate and guanosine pentaphosphate), which binds to RNAP and regulates promoter 
selection. 
A criteria of |log2 fold change| > 0.5 for all strain contrasts was used to remove genes 
that exhibited small variations in transcript abundance. Thirteen genes had a log2 fold change 
< -0.5 for all strain contrasts: bssS, fliR, rcsA, dsrA, mntH, ssrA, speB, rplB, ugpQ, waaG, 
yjbE, phnP, and osmY. Eleven genes exhibited a log2 fold change > 0.5 in all strain contrasts: 
hofC, hofB, btuF, mtn, fdnH, fdnI, pykA, nrdB, pka, yfiR, yfiN, yfiB, glyS, mtlD, fadA, and 
fadB. The gene waaG was previously studied and contains an insertion sequence in the 
parent strain and is excluded from additional investigation into the effect of the rpoC 
mutation. Interestingly, the transcript abundance for waaG is greater in the parent strain with 
the non-functional copy of the gene. We attribute this to poor alignment in this region due to 
the insertion sequence. 
We also considered that genes with sigma 70 promoters may be influenced by other 
mutations present in LAR1. We examined the gene regulatory network generated by EVA for 
the basR mutations and included the next three levels of gene regulation, which included 130 
genes. When cross-referencing the list of genes downstream of these mutations with the 
differentially expressed genes mentioned above, we identify osmY and fliR as being 
indirectly regulated by the BasR transcription factor. In the case of osmY, BasR is a 
transcriptional activator for csgD (Ogasawara, Shinohara, Yamamoto, & Ishihama, 2012). 
CsgD represses transcription of fliZ (Dudin, Geiselmann, Ogasawara, Ishihama, & Lacour, 
2014), and FliZ represses transcription of csgD and osmY. For fliR (Pesavento et al., 2008; 
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Pesavento & Hengge, 2012), BasR activates transcription of qseB (Guckes et al., 2013), 
QseB is believed to activate transcription of flhC and flhD (Sperandio, Torres, & Kaper, 
2002), and FlhDC is a transcriptional activator for fliR (Brandi, Giangrossi, Giuliodori, & 
Falconi, 2016). In both cases, it is possible that the differences in transcript abundance 
between strains are indirectly affected by the basR mutation. 
GO enrichment highlighted the relationship between fdnH and fdnI as components of 
the formate dehydrogenase complex but did not give insight into larger trends among the 
genes. Because these genes are in the same operon and co-transcribed, it is not surprising that 
they appeared in the same list. Other operons that appeared in our analysis include yfiRNB, 
fadAB, and hofBC. The hofBC genes have sequence similarity to protein secretion and 
fimbrial assembly genes (Whitchurch & Mattick, 1994) and yfiRNB genes is involved in 
exopolysaccharide biosynthesis in Pseudomonas aeruginosa. Because of our previous work 
characterizing the altered membrane and extracellular polymeric substances in LAR1, we 
believe these operons to be worthy of investigation. For these cases, we shall perform 
knockout experiments on the entire operon as a first test for relevance to evolved strain 
phenotype. 
The fadAB operon is also of interest because of the genetic interventions introduced 
in the parent strain to modify the metabolism for improved fatty acid production. In ML115, 
a fadD knockout was added to deactivate the fatty acid beta-oxidation pathway (Figure 4.2). 
Two additional genetic interventions were made to inactivate acetate production: the deletion 
of poxB and ack-pta (Li et al., 2012). 
 111 
 
 
Figure 4.2  Fatty acid beta oxidation pathway. 
The fatty acid beta oxidation pathway in E. coli (image retrieved from EcoCyc). Under 
aerobic conditions, FadD, FadB, and FadA break down fatty acids. 
 
With fatty acyl-CoA synthetase (fadD) absent in ML115 and LAR1, it is surprising to see an 
increase in expression of fadA and fadB and even more interesting that there is greater 
transcript abundance for both genes in LAR1 when compared to ML115. 
Other interesting genes from our list of candidates include yjbE, the most strongly 
downregulated gene for all LAR1-ML115 strain contrasts, for its role in biofilm formation 
and involvement in the production of extracellular polysaccharides (Ferrières, Aslam, 
Cooper, & Clarke, 2007). The gene bssS is also involved in biofilm formation and is the 
second most strongly downregulated gene. A bssS deletion has previously been reported as 
increasing biofilm formation and motility (Domka, Lee, & Wood, 2006). 
Upon examining our candidate genes in the context of the gene regulatory and 
metabolic network generated by EVA, we find expected interactions that connect fadA and 
fadB as well as fdnH and fdnI (Figure 4.4A). Previously unexamined interactions are found 
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between pykA and mtlD (Figure 4.4B). These genes are involved in the super pathway of 
glycolysis and Entner-Dourdoff. Both genes have a higher transcript abundance in LAR1 
compared to ML115. A cluster containing rcsA and yjbE is also found in the network (Figure 
4.4C). The gene yjbE was previously named as a gene of interest due to its role in 
extracellular polysaccharide production and because it exhibits the largest strain contrast. 
RcsAB is believed to activate transcription of  yjbE (Ferrières et al., 2007) which would be 
consistent with a downregulation of rcsA and subsequent downregulation of yjbE as we see 
in LAR1 compared to ML115. 
 
Expression of genes in the BasR regulon 
Differentially expressed genes were compared with genes in the BasS-R regulon and 
up to three downstream levels of transcriptional regulation. We hypothesized that the 
production condition with the pJMY-EEI82564 plasmid would cause the most significant 
change in activity for the BasS-R two component signal transduction system, resulting in 
variation in expression among genes in the its regulon. To investigate genes in the BasR 
regulon, we used EVA to construct a gene regulatory and metabolic network that represented 
genes downstream of the transcription factor and included additional transcriptional 
regulation activities as previously described (Chen et al., 2018). Onto this network, we 
applied fold-change data for the strain contrast of interest (Figure 4.4) and BasR gene 
regulation activities. The variation between expected BasR transcription factor activity and 
observed direction in fold change for regulated genes speaks to the complexity of gene 
regulation and the fact that multiple regulators may affect gene expression. From our network 
analysis, we identified two operons of interest based on differential expression and gene 
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function: arnBCADTEF and csgDEFG. Both operons will be knocked out and tested for 
effect on specific growth rate in 10 mM C8. 
 
bssS knockout improves specific growth rate at 10 mM C8 
The gene bssS, a regulator of biofilm, exhibited a consistent direction in fold change 
for all strain contrasts. In all cases, the transcript abundance of bssS was lower in LAR1 than 
ML115. Because of its reported role in biofilm formation and motility, it was selected for 
additional study. bssS has promoters associated with sigma 70 and sigma 32, the primary 
sigma factor for heat shock response. A knockout of bssS was introduced into the parent 
strain, ML115, with the waaG repair. We have already shown the profound effect damaging 
waaG has on phenotype but wish to examine if knocking out bssS contributes to octanoic 
acid tolerance. To test this, we measured growth rate of our reconstructed strains in 0 and 10 
mM C8 (Figure 4.5A, B, and C). We find that specific growth rate is improved when bssS is 
knocked out (Figure 4.5D and E) compared with the parent strain with functional waaG, 
however this single intervention is not sufficient to recreate the phenotype observed with the 
variant rpoC (Figure 4.5B).  
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Figure 4.3  EVA-generated gene regulatory and metabolic networks for genes in Table 3.2. 
A. The full network for all genes of interest: 283 nodes and 283 edges; B. Selected cluster 
from (A) with pykA and mtlD genes; C. The largest cluster in the network contains regulatory 
interactions that connect rcsA and yjbE.  
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Table 4.2  Genes with consistent and statistically significant fold changes for all strain 
contrasts. 
Genes are ordered by the smallest log2 fold change (LFC) among all strain contrasts, 
ascending, with a divider separating genes that had a lower transcript abundance in LAR1 
with genes that had a higher transcript abundance in LAR1. 
b-num Name Product LAR1-ML115 (min LFC) 
b4026 yjbE extracellular polysaccharide production threonine-
rich protein 
-3.02 
b1060 bssS biofilm regulator -1.78 
b3449 ugpQ glycerophosphodiester phosphodiesterase, cytosolic -1.38 
b1954 dsrA small regulatory RNA -1.32 
b4376 osmY periplasmic protein -1.23 
b2621 ssrA tmRNA -1.21 
b3631 waaG glucosyltransferase I -1.20 
b2392 mntH manganese/divalent cation transporter -0.99 
b1951 rcsA transcriptional regulator of colanic acid capsular 
biosynthesis 
-0.89 
b1950 fliR flagellar export pore protein -0.89 
b4092 phnP 5-phospho-alpha-D-ribosyl 1,2-cyclic phosphate 
phosphodiesterase 
-0.67 
b3317 rplB 50S ribosomal subunit protein L2 -0.58 
b2937 speB agmatinase -0.52 
b0244 thrW Thr tRNA -0.47 
b3924 fpr ferredoxin-NADP reductase -0.44 
b0880 cspD inhibitor of DNA replication, cold shock protein 
homolog 
-0.43 
b0143 pcnB poly(A) polymerase -0.41 
b0345 lacI lactose-inducible lac operon transcriptional repressor -0.33 
b2558 mltF membrane-bound lytic transglycosylase F, murein 
hydrolase 
0.29 
b2509 xseA exonuclease VII, large subunit 0.41 
b2686 emrB multidrug efflux system protein 0.42 
b2913 serA D-3-phosphoglycerate dehydrogenase 0.43 
b1854 pykA pyruvate kinase II 0.51 
b2603 yfiR putative periplasmic inhibitor of YfiN activity 0.69 
b3600 mtlD mannitol-1-phosphate dehydrogenase, NAD-
dependent 
0.75 
b2235 nrdB ribonucleoside-diphosphate reductase 1, beta subunit, 
ferritin-like protein 
0.76 
b3845 fadA 3-ketoacyl-CoA thiolase (thiolase I) 0.76 
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Table 4.2 (continued) 
 
 
b-num Name Product LAR1-ML115 (min LFC) 
b3559 glyS glycine tRNA synthetase, beta subunit 0.90 
b0106 hofC assembly protein in type IV pilin biogenesis, 
transmembrane protein 
0.91 
b0159 mtn 5'-methylthioadenosine/S-adenosylhomocysteine 
nucleosidase 
0.93 
b0107 hofB T2SE secretion family protein; P-loop ATPase 
superfamily protein 
0.94 
b1476 fdnI formate dehydrogenase-N, cytochrome B556 
(gamma) subunit, nitrate-inducible 
0.97 
b2584 pka protein lysine acetyltransferase 1.12 
b3846 fadB fused 3-hydroxybutyryl-CoA epimerase/delta(3)-cis-
delta(2)-trans-enoyl-CoA isomerase/enoyl-CoA 
hydratase/3-hydroxyacyl-CoA dehydrogenase 
1.16 
b2605 yfiB OM lipoprotein putative positive effector of YfiN 
activity 
1.24 
b0158 btuF vitamin B12 transporter subunit: periplasmic-binding 
component of ABC superfamily 
1.35 
b1475 fdnH formate dehydrogenase-N, Fe-S (beta) subunit, 
nitrate-inducible 
1.40 
b2604 yfiN putative membrane-anchored diguanylate cyclase 
with an N-terminal periplasmic domain 
1.43 
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Figure 4.4  EVA-generated network with RNA-seq data. 
One level of gene regulation represented using mutated features as seed nodes in the 
network. Blue node borders correspond to mutated features. Colored interaction arrows 
show gene regulation; red = activation, green = repression. Node coloring depicts the strain 
contrast for the production condition during the exponential growth phase: log2 fold change 
for LAR1+pJMY-EEI82564 – ML115+pJMY-EEI82564 at 12 hours. Emphasized node 
borders indicate p-value < 0.05.  
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Figure 4.5  The effect on specific growth rate of ∆bssS in 0 and 10 mM C8. 
A. growth rate for the parent strain with repaired waaG; B. growth rate for the parent strain 
with repaired waaG and rpoC mutation; C. growth rate for the parent strain with repaired 
waaG and bssS knockout; D. the effect of the bssS knockout on growth in 0 mM C8; E. the 
effect of the bssS knockout on growth in 10 mM C8. 
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Conclusions 
In this work we have performed RNA-seq experiments for the parent and evolved 
strains and identified genes that are consistently differentially expressed in different growth 
phases and in control and fatty acid production conditions. We additionally examined genes 
with significant strain contrasts and selected candidates for further study. We modified EVA 
to construct a gene regulatory and metabolic network using this set of genes as seeds. From 
this network, we were able to find additional connections through gene regulation among 
genes of interest. The network also highlighted metabolic pathways that could be affected by 
differentially expressed genes. We also visualized fold-change data on the EVA network for 
the BasR regulon. 
We have begun constructing gene knockout strains based on our list of candidate 
genes to test their effect on growth with exogenous C8. Thus far, ∆bssS has been tested and 
found to improve specific growth rate but does not account for the improvement we see from 
the rpoC mutation. The effects of the variant basR and rpoC genes on transcription may be 
broad and could involve multiple genes and pathways. We have presented our 
bioinformatics-based approach to identifying gene candidates for further investigation based 
on relationship to mutated features, differential expression in transcriptomic analysis, and 
gene regulation and metabolic network relationships. 
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CHAPTER 5.    SUMMARY, FUTURE WORK, AND CONCLUSIONS 
Microbial evolution as a strategy for strain engineering has been shown to be an 
effective tool for enhancing tolerance of E. coli to carboxylic acids for greater yields, titers, 
and productivity. We also examined case studies that employed this strategy for studying 
antibiotic resistance in bacteria. In both cases, continuous fermentation under selective 
pressure is used to obtain strains that exhibit a desired phenotype. Such evolution studies 
may be performed iteratively and can also include targeted genetic interventions. In all cases, 
the metabolic evolution itself is a black box technique and the mutations acquired during the 
experiment are not known until genomes of evolved strains are sequenced. Reverse 
engineering of evolved strains necessary to identify genetic variations from the parent strain 
and discern which mutations are relevant the evolved phenotype and by what mechanisms. 
The task of reverse engineering evolved strains remains a significant challenge. 
Inconsistencies among short read assembly software, sequencing errors, and complex 
mutations such as rearrangements and large indels can lead to inaccurate mutation 
predictions. Verification of predicted mutations by PCR and Sanger sequencing is necessary 
to have confidence in genome annotations. 
This work has focused primarily on characterizing mutations identified in 
comparative genomic analysis with the goal of relating genotype to phenotype, a significant 
challenge in microbial engineering. Chapter 2 present the software developed to work toward 
this goal and support reverse engineering efforts. We present a strategy that is appropriate for 
many types of mutations, but could be extended as analysis methods advance. While we built 
our software for E. coli, the same concepts apply to other bacterial systems. To implement a 
version of EVA for a different organism, a complete genome, gene models, and sufficient 
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gene regulation and metabolic pathway data are required. Organisms without well-
characterized gene regulation and metabolism could still benefit from the annotation and 
sequence analysis components of EVA. Even for E. coli, we must rely on incomplete models 
of gene regulation and cellular metabolism, and so our results are also incomplete. The best 
publicly available databases for this model organism may not include some published 
regulatory links, such as was the case for the BasR regulon. Other regulation links may only 
be from computation predictions based on sequence similarity to known binding sites. 
There is the additional challenge of presenting meaningful biological network 
information without including too much extraneous information. To provide options for 
biologists, EVA generates biological networks in three ways: a complete network with all 
available regulatory links, a mutation-interaction network with all nodes and edges reachable 
by two or more mutations, and a shortest-path network with minimal paths between mutated 
features. Additional network analysis and statistics could be derived from these networks, an 
analysis that could be increasingly valuable as the number of mutations in an experiment 
grows or in cases where additional regulatory steps are included in the network. 
In Chapter 3, we used the EVA software to aid in mutation interpretation for E. coli 
evolved for improved octanoic acid tolerance. In Chapter 4, we continued our reverse 
engineering efforts with an associated RNA-seq study. The utilization of transcriptomic and 
other omics data in reverse engineering microbial strains provides valuable information about 
cellular activities which cannot be known from genomics studies alone. The gene regulatory 
and metabolic networks generated by EVA and using mutated features as seed nodes are 
readily integrated with transcriptomics data. In addition, we modified EVA to generate new 
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networks from differentially expressed genes and were able to identify relationships among 
these genes that may point to the underlying mechanisms responsible for phenotype. 
It would be interesting to incorporate other types of omics data (e.g., proteomics, flux 
analysis) into our analysis in the future. Additionally, using EVA networks to build simple 
models for gene activation and repression could aid in interpretation and potentially identify 
missing regulatory links. And finally, utilizing EVA for rational engineering could provide 
researchers with multiple targets for incorporating a desired genomic intervention, such as 
promoter or transcription factor binding site modification.
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APPENDIX A.    IDENTIFICATION OF MUTATIONS IN EVOLVED BACTERIAL 
GENOMES 
Methods book chapter in: Hal S. Alper (ed.), Systems Metabolic Engineering: 
Methods and Protocols, Methods in Molecular Biology, vol. 985:249-267 
Liam Royce, Erin Boggess, Tao Jin, Julie Dickerson, Laura Jarboe 
Summary 
Directed laboratory evolution is a common technique to obtain an evolved bacteria 
strain with a desired phenotype. This technique is especially useful as a supplement to 
rational engineering for complex phenotypes such as increased biocatalyst tolerance to toxic 
compounds. However, reverse engineering efforts are required in order to identify the 
mutations that occurred, including single polymorphisms (SNPs), insertions/deletions 
(indels), duplications, and rearrangements. In this protocol, we describe the steps to 1) obtain 
and sequence the genomic DNA 2) process and analyze the genomic DNA sequence data, 
and 3) verify the mutations by Sanger resequencing. 
 
Introduction 
Bacteria acting as biocatalysts for production of biorenewable fuels and chemicals are 
often faced with product-mediated inhibition. For example, ethanol was shown to negatively 
impact growth and structure of E. coli and yeast (Ingram & Buttke, 1984; Trinh, Huffer, 
Clark, Blanch, & Clark, 2010); the effects of succinate were revealed on the membrane and 
enzymes of yeast (Duro & Serrano, 1981; Smith, Janknecht, & Maher, 2007); butanol was 
shown to inhibit the growth and sugar uptake rate of Clostridium acetobutylicum (Schwarz, 
Kuit, Grimmler, Ehrenreich, & Kengen, 2012; Winkler & Kao, 2011). 
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Lignocellulosic biomass has been extensively utilized as a source of carbon and 
energy for the fermentative production of ethanol and other biorenewable fuels (Jarboe, 
Grabar, Yomano, Shanmugan, & Ingram, 2007; Jørgensen, Kristensen, & Felby, 2007; C. Li, 
Qian, & Zhao, 2008). However, the sugar streams released from this biomass frequently 
contain inhibitory contaminants that inhibit the growth and substrate utilization of 
microorganism (Miller, Jarboe, Turner, et al., 2009; Zaldivar & Ingram, 1999; Zaldivar, 
Martinez, & Ingram, 1999). 
Thus, the fermentative production of biorenewable fuels and chemicals is associated 
with both inhibitory contaminants in the feedstock and inhibitory products; in these cases, it 
can be sometimes useful to increase the tolerance of the biocatalyst to these inhibitory 
compounds. Metabolic evolution is frequently used to increase the tolerance of bacteria to 
inhibitory compounds. Directed evolution is when researchers can enhance desired features, 
such as increased tolerance of inhibitory compounds, by selecting for random mutations 
under appropriate selective pressure. While metabolic evolution is sufficient to acquire a 
strain with the desired phenotype, it is often of interest to identify the mutations acquired 
during the evolutionary process. 
Reverse engineering can yield a roadmap for reproducing the desired phenotype or 
behavior in other biocatalysts. This method begins with whole-genome sequencing using 
high-throughput sequencing technology, such as Illumina's sequencing by synthesis 
technique. Bioinformatics methods known as de novo assembly and mapping (or alignment) 
are used to analyze the short read data and reconstruct the genome (Langmead, Trapnell, 
Pop, & Salzberg, 2009; H. Li & Durbin, 2009; H. Li et al., 2009). By obtaining DNA 
sequences of the parent and evolved organism genomes, it is possible to perform a 
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comparative analysis and identify variations in the evolved strain. Isolation of bacteria 
genomes is a standard procedure. Sequencing platforms are changing rapidly in their 
throughput and chemistry to increase availability and fidelity of sequence data (Metzker, 
2010). As sequencing data becomes more readily available, there are many challenges to the 
processing and analysis of sequence data, which is costly and time consuming. Thus, 
automation by programs alleviates the burden of manual analysis. The finishing step and gap 
filling in DNA sequence analysis is the bottleneck in automation (D. Gordon, Abajian, & 
Green, 1998). In the recent decade, there has been a great amount of improvement in 
automating the process with computer programs; however, this step still requires human 
intervention. 
As the genotype of the evolved strain is defined, hypotheses are formed regarding the 
roles of mutations in the context of the phenotype. As researchers elucidate which mutations 
improve fitness, the intent is to infer the mechanisms that lead to the increased tolerance to 
toxicity and then proceed with rational engineering techniques (Jarboe et al., 2007; Miller, 
Jarboe, Yomano, et al., 2009). This can also enable to identify the function of the 
undercharacterized enzymes and pathways (Jarboe, 2011). However, the focus of this chapter 
is to describe the use of genome sequence analysis to identify the mutations acquired in an 
evolved strain. Determination of which of these mutations impact the phenotype and 
understanding the mechanism of the mutation’s function is outside the scope of this chapter. 
 
Materials 
All materials used are standard kits and reagents. Software for high throughput 
sequence analysis generally requires UNIX/Linux operating systems with a large 
amount of memory and storage. Both free and commercial software packages are available 
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for analyzing high-throughput sequencing data. All software included in this protocol is open 
source unless otherwise noted. 
 
Genomic DNA Purification and Sequencing 
1. Lauria Broth (LB) for growing bacteria cells: dissolve at 25 g/L in nanopure water 
and filter-sterilize using a 0.22 CA bottle top filter. 
2. 1.5mL microfuge tubes and 50mL centrifuge tubes for sample processing. 
3. QIAGEN DNeasy® Blood & Tissue kit for genomic DNA isolation and purification. 
Buy RNase A and 100 % ethanol separately. 
4. Accublock Digital Dry Bath for temperature-controlled incubation. 
5. NanoDrop Spectrophotometer for genomic DNA quantification and quality control. 
6. Illumina cBot System and Illumina TruSeq PE Cluster Kit -GA for cluster generation, 
Illumina GAII sequencing instrument for short-read whole genome sequencing 
(available at a university core facility, prices vary). 
 
Bioinformatics Software for High-Throughput Sequence Data 
1. Galaxy is a scientific workflow system for high-throughput sequence data 
preprocessing, integration, and analysis. A free public server is available, but most 
users will need to download and install the open source Galaxy software locally due 
to the upload limitations and to preserve data privacy. UNIX/Linux and Mac OS X 
are supported and a recent version of Python must be installed (Blankenberg et al., 
2010; Giardine et al., 2005; Goecks, Nekrutenko, Taylor, & Team, 2010). 
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2. FastQC provides quality control checks for raw sequence data and generates 
summary graphs and basic statistics. FastQC is available through the Galaxy interface 
or for download and independent installation (Andrews, 2012). 
3. FASTX-Toolkit is a collection of scripts for manipulating raw sequence data. It 
includes conversion, trimming, and filtering tools and will generate some quality 
statistics. The FASTX-Toolkit is distributed with Galaxy or can be downloaded and 
installed independently (A. Gordon). 
4. Mapping software: Bowtie, Bowtie 2, and BWA are popular short read aligners that 
distributed under the GPLv3 license. Bowtie and BWA are distributed with Galaxy. 
Memory requirements vary by algorithm and input data, but at least 2GB memory 
required and at least 4GB is recommended. Multiple processors can also improve 
alignment speed. It is critical to read the manual for mapping software because 
different parameters will generate different alignments. 
5. de novo assembly software: Velvet and ABySS (available for download and 
distributed under the GPLv3 license) are examples the many available de Buijn 
graph-based assemblers (Simpson et al., 2009; Zerbino & Birney, 2008). Other 
assemblers that use an overlap/layout/consensus approach are available, but take 
considerably longer to assemble short reads and are not considered for this protocol. 
While many assemblers support 32-bit platforms, a 64-bit machine is recommended 
and memory requirements vary by algorithm, short read data, and selected k-mer 
length. It is critical to read the assembler manuals because different parameters 
generate different contigs/scaffolds. 
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6. Basic Local Alignment Search Tool (BLAST) is the most widely used sequence 
similarity tool. A web interface is available through NCBI, but a local installation of 
the BLAST+ open source applications provide a command line usage (Camacho et 
al., 2009). 
7. SAMtools is a collection of utilities for manipulating alignments. BCFtools, which is 
distributed with SAMtools, performs variant calling. SAMtools is distributed with 
Galaxy and can also be independently installed (H. Li & Durbin, 2009; H. Li et al., 
2009). 
 
Mutation Verification 
1. Primer3 software (distributed under GPLv2) for primer design and primers (Rozen & 
Skaletsky, 2000). 
2. Plate Spinner Centrifuge. 
3. Commercial 10mM Tris-HCl, pH=8.5 buffer. 
4. 96-well PCR plates. 
5. Polymerase Chain Reaction (PCR) materials: QIAGEN® Taq PCR Master Mix Kit or 
QIAGEN® LongRange PCR Kit and Strain Genomic DNA (from material 2.1.1). 
6. Gel loading materials: Blue (6X) Gel Loading Dye and ethidium bromide, 1% 
Solution/Molecular Biology, for visualization of PCR products and 1 Kb Plus DNA 
Ladder for size determination. 
7. 50X TAE: 242g Tris base, 57.1ml Glacial Acetic Acid, 18.6g EDTA dissolved in 
900mL nanopure water. Add make up nanopure water to 1L. 
8. TAE DNA gel for separating DNA fragments: dissolve 1% W/V Agarose in 1X TAE. 
9. Gel electrophoresis equipment. 
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10. PCR Purification Kit to purify PCR products. 
11. DNA sequence finishing software Phred/Phrap/Consed or CodonCode Aligner 
(Ewing & Green, 1998; Ewing, Hillier, Wendl, & Green, 1998; D. Gordon et al., 
1998). 
12. Thermal Cycler for generating PCR products. 
 
Methods 
Obtaining the evolved strain and interpretation of mutation function is outside the 
scope of this paper. Here we restrict this protocol to DNA purification, genome sequencing, 
analysis and verification. 
 
Obtain Sequence Data 
1. After obtaining an evolved bacteria colony isolate, prepare to use the QIAGEN DNeasy® 
blood & tissue kit. Other commercial kits can also be used to isolate the genomic DNA. 
First, grow the parent strain (before the evolution experiment) and the evolved strain 
overnight in 25 mL LB. 
2. Follow the QIAGEN DNeasy® Blood & Tissue kit protocol for gram-negative bacteria. 
2.1. Harvest cells (maximum 2 x 109 cells) in 50mL centrifuge tube by centrifuging for 
20 minutes at 4°C, ~5,000xg. Discard supernatant (see Note 1). 
2.2. Resuspend pellet in 180 µl Buffer ATL and transfer to a microcentrifuge tube. 
2.3. Add 20 µl proteinase K. Mix thoroughly by vortexing, and incubate at 56°C in a 
temperature controlled waterbath until the cells are completely lysed (3h). 
Vortex every hour. 
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2.4. Add 20 µl RNase A, briefly vortex, and incubate at room temperature for 2 
minutes. 
2.5. Add 200 µl Buffer AL, and mix thoroughly by vortexing. Then add 200 µl 100 
% ethanol and mix again thoroughly by vortexing (see Note 2). 
2.6. Pipet the sample into the DNeasy Mini spin column and centrifuge at maximum 
speed for 1 minute. Discard flow-through (see Note 3). 
2.7. Add 500 µl Buffer AW1 and centrifuge at maximum speed for 1 minute. 
2.8. Add 500 µl Buffer AW2, and centrifuge at maximum speed for 1 minute. 
Discard flow-through and centrifuge again at maximum speed for 1 minute to dry the 
column (see Note 4). 
2.9. Place the DNeasy Mini spin column in a clean 1.5 ml microfuge tube, and pipet 100 
µl Buffer AE directly onto the DNeasy membrane. Incubate at room temperature for 
1 min, and then centrifuge at maximum speed for 1 min to elute. Add another 100 µl 
Buffer AE, incubate for 1 minute, and then centrifuge at maximum speed for 1 
minute (see Note 5). Freeze DNA at -20°C or proceed directly to the next step. 
3. Check the quality of the genomic DNA on a nanodrop. First, blank the spectrophotometer 
with 1 µl nanopure water. Wipe away the water, then add the sample. One should see a 
smooth profile with a minimum at 230nm and a maximum at 260nm. Typical values 
should be ~20 µg genomic DNA, 280/260 value of ≥ 1.8, and a 260/230 value of ≥ 2. If 
the quality is too low, repeat the wash steps 2.7-2.9 with a new column. 
4. Submit ≥ 2 µg/sample genomic DNA (at least 1 parent strain sample and 1 evolved strain 
sample) to a core facility for whole genome sequencing. There are many options to 
choose which sequencing instrument and which sequencing method; currently the DNA 
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core facility at Iowa State University has a GAII sequencer from Illumina, INC. 75-cycle 
paired-end sequencing is recommended as the researcher obtains more reads at a higher 
quality. To date, Illumina offers 150-cycle paired-end data with the GAII sequencer and 
100-cycle paired-end data on their HiSeq instrument. If submitting more than one sample, 
indexing is the best option as one pays only for one sequencing lane. Indexing allows to a 
maximum of 12 samples in a single lane. The workflow of the Illumina platform is shown 
in Figure 1. Refer to the Illumina website for their sequencing technology: 
http://www.illumina.com/technology/sequencing_technology.ilmn (see Note 6). 
 
Preprocess Sequence Data 
High throughput sequence data is most commonly stored in FASTQ format. FASTQ 
format represents each read as a set of lines: header, sequence, sequence ID (optional), and 
quality scores in ASCII encoding. These text files typically have a .fq, .fastq, or .txt 
extension. 
1. Before beginning analysis, identify what quality scoring encoding is associated with the 
raw data. Different Illumina genome analyzer pipeline software versions use different 
scoring scheme variations (e.g., Illumina 1.3+, Illumina 1.5+, and Illumina 1.8+). If there 
is difficulty identifying which encoding is used, FastQC includes this in its output. 
Software user manuals will specify if a particular scoring scheme is expected as input and 
it may be necessary to perform a conversion prior to analysis using Galaxy, the FASTX-
Toolkit, or using a “Bio*” library in the language of your choice (e.g., BioPerl, 
BioPython, BioRuby, BioJava). 
 135 
 
2. Use FastQC to perform an initial quality assessment of raw data. Launch the FastQC GUI 
and open FASTQ data files to generate all FastQC reports at once. Reports and graphs are 
presented in HTML format and can be saved for reference. 
Examine per-base quality, per-sequence quality, per-base content, and length 
distributions (not applicable for Illumina reads). Also check for overrepresentation of 
sequences and if they correspond to contaminants or PCR artifacts (in addition to 
common artifacts provided by FastQC users may supply sequences of potential 
contaminants to screen for). 
Use the summary icons (green: normal, orange: slightly abnormal, and red: very unusual) 
as guidelines in the following preprocessing steps. It is important to acknowledge that not 
all preprocessing steps will be necessary for all data and also that having small 
abnormalities may be acceptable in the context of the data and should not prevent a 
researcher from proceeding with analysis. 
3. Perform read trimming using the FASTX-Toolkit if necessary. Read quality deteriorates 
with position and base calls near the end of a read are more prone to error. An appropriate 
length to trim may be determined from FastQC output. Use the fastx-trimmer 
command from the FASTX-Toolkit: 
$ fastx_trimmer [-f N] [-l N] [-i INFILE] [-o 
OUTFILE] 
Where[-f N] specifies the first base to keep (default is 1), [-l N] specifies the last 
base to keep (default is entire read), INFILE specifies the FASTQ file and OUTFILE is 
the name to give the trimmed data file. More advanced techniques allow for adaptive read 
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trimming, however reads of varied length may not be acceptable as input for all analysis 
software. 
4. Filter reads by overall quality with the FASTX-Toolkit: 
$ fastq_quality_filter [-q N] [-p N] [-i INFILE] 
[-o OUTFILE] 
The minimum quality score to keep is[-q N] and [-p N]is the minimum percentage 
of bases that must have [-q] quality. 
5. Remove sequencing artifacts, described as reads that are predominantly one base (e.g., 
AAAAAAAAAAAAAAAACAAACA), using the FASTX-Toolkit: 
$ fastx_artifacts_filter [-i INFILE] [-o OUTFILE] 
Where INFILE specifies the FASTQ file and OUTFILE is the name to give the filtered 
data file. 
6. Remove adapters sequences (identified as overrepresented sequences in the FastQC 
report or defined in protocol) with the FASTX-Toolkit: 
$ fastx_clipper [-a ADAPTER] [-l N] [-i INFILE] [- 
o OUTFILE] 
Where [-a ADAPTER] is the adapter sequence that is to be removed from 3'-end of 
sequences, [-l N] is the minimum length of reads to keep in the dataset (default is 5), 
INFILE specifies the FASTQ file, and OUTFILE is the name to give the filtered data 
file. 
7. Resubmit filtered and trimmed data to FastQC to verify improved data quality and 
recalculate data summary statistics before proceeding with analysis. 
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Map Short Reads to Reference Genome 
1. Build a reference index (using the reference genome in FASTA format) using the 
alignment algorithm of your choice, e.g., 
$ bwa index [-p prefix] [-a algoType] ref.fa # BWA 
$ bowtie-build [options]* ref.fa <prefix> # Bowtie 
$ bowtie2-build [options]* ref.fa <prefix> #Bowtie 2 
Where ref.fa is the reference genome in FASTA format, prefix is the prefix of the 
output database and also the database filename. Additional options are defined in the 
corresponding user manuals. Using the genome of the parent strain as the reference yields 
the best alignments. If the genome of the parent strain has not been sequenced, download 
the genome of the wild-type laboratory strain from a public online database such as NCBI 
RefSeq. One benefit of using the wildtype genome as reference is the ability to easily 
leverage existing annotation in publically available databases (e.g., BioCyc). 
2. Align reads to the reference and generate a SAM file. The SAM file format is a TAB-
delimited text file that contains information such as alignment position (or '*' for 
unaligned reads) and mapping quality for each read and is the common output format for 
aligners. SAMtools performs conversions between SAM and a compressed and indexed 
binary format called BAM. 
3. Assess overall alignment quality by reviewing the summary statistics generated by 
mapping software such as the percentage of reads that aligned to the reference genome. 
Use SAMtools to calculate read depths for each position of the genome: 
$ samtools depth aln.sorted.bam > depth.txt 
Where aln.sorted.bam is the sorted BAM file. The output file, depth.txt, 
contains one line for each position in the reference genome. The second column is the 
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coordinate and the third column is the number of reads that cover that position. The 
SAMtools depth utility does not report positions where read depth is zero, thus the 
number of lines in the file is equal to the number of bases where coverage is non-zero. 
Alternative, specify a depth cutoff to ignore very small read depths (i.e., do not consider 
depth = 1 as genome coverage). Calculate base coverage with one of the following: 
$ wc -l depth.txt # depth > 0 
$ awk '$3 > $N {i++} END{print i}' depth.txt# depth > N 
Divide base coverage by genome size to obtain the percentage of the 
genome covered by reads. 
Map quality scores can also be examined by investigating column 5 
(MAPQ) of the SAM file. 
 
De novo Assembly 
De novo assembly and mapping of short reads to a reference sequence are 
fundamentally different analysis procedures. Assembly of the genomes of evolved bacterial 
strains can be used to search for novel insertions and complex mutations that are difficult for 
mapping software to identify. Additionally, results from assembly methods can provide 
support for proposed alignments. 
Assembly of short read data does not use a reference sequence and instead tiles reads 
to generate sequences called contigs. Incorporating the average distance between paired-end 
reads (called the insert size) is used to join contigs into scaffolds. The most important 
parameter in de Bruijn graph based assembly algorithms is the hash length, which is also 
known as the k-mer length. Large k-mer values require longer overlap between reads in order 
for them to be assembled (therefore the k-mer value may not be larger than the read length). 
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Conversely, small k-mer values require short overlap which results in increased sensitivity, 
but decreased specificity. The experimenter must provide the k-value parameter and there is 
no method to find the optimal value. Because of this, it is recommended that researchers test 
multiple k-mers and then compare several assemblies before proceeding. 
1. Assemble short read data with the assembler of your choice. Test multiple k-mer values 
and calculate the total number of contigs, N50, and N90 for each assembly (typically 
reported by assembly software). 
2. Proceed with the “best” assemblies such that the number of contigs is minimized and the 
N50 and N90 are maximized. 
 
Identify Variations in Evolved Strains 
1. Identify single nucleotide polymorphisms (SNPs) and short insertions/deletions (indels) 
for an alignment using SAMtools/BCFtools: 
$ samtools mpileup -uf ref.fa aln.bam | bcftools view -bvcg 
- > var.raw.bcf 
Where ref.fa specifies the reference genome in FASTA format and aln.bam is a 
binary alignment file. The output is a binary file (BCF) for Variant Call Format (VCF) 
TAB-delimited files. VCF is standard for storing information about variants in 
alignment data. 
2. Find large deletions by inspecting of read depth (the number of reads mapped to a 
specific position on the reference genome). Calculate read depth values using SAMtools: 
$ samtools idxstats aln.bam 
Regions with zero or very low read depth may indicate deletions. Determining what 
qualifies as “low” read depth may be aided by examining the read depth distribution. 
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3. Use assembly results to distinguish complex mutations such as large insertions, 
duplications, and inversions that are difficult for mapping algorithms to identify. Align 
contigs to a reference genome or an alignment consensus sequence. First, generate the 
consensus sequence from an alignment file with SAMtools: 
$ samtools mpileup -uf ref.fa aln.bam | bcftools view -cg - 
| vcfutils.pl vcf2fq > cns.fq 
Where cns.fq is the output consensus sequence. Next, BLAST contigs against these 
sequences to reveal sequence variations. Syntenic dotplots can also be used to visually 
identify discontinuities. 
4. If possible, leverage reference genome annotation to form hypotheses about the effects of 
mutation. Verification by targeted sequencing can be used to confirm mutations. More 
advanced experimentation is necessary to confirm hypothesized effects. 
 
Verify Mutations 
1. Obtain a list of mutations from the above analysis and the sequences of the regions of 
interest. 
2. There are two approaches for obtaining primers for PCR: for genes and for noncoding 
regions. 
2.1. For mutated regions containing open reading frames (ORFs or genes), first note how 
large the gene is and round up to the nearest 1,000. Add the additional sequences 
upstream and downstream of the gene equally. Then split the sequence into 1,000 bp 
segments (see Note 7 and Note 8). This method will give you room to pick optimal 
primers to include the entire sequence of interest. Use the Primer3 program to design 
optimal primers whose PCR product size range is 851-1,000 bp in length (see Note 
 141 
 
9). Paste in the first 1,000 bp sequence, use the other default values, and click “Pick 
Primers”. Select any of the suggested primers, noting where they bind to the template 
and the product size. Add the next 1,000 bp block of sequence and repeat until 
complete. 
2.2. For mutated regions within a non-coding region (NCR), take a 1,000bp segment of 
DNA sequence and set the suspected mutation in the middle (~500bp from the first 
base). This ensures good sequencing data of this region. Use the Primer3 program for 
NCRs the same way for ORFs (see Note 10). 
3. For long sequencing regions (>1kb), the above method will have gaps in the total 
sequence. In order to fill in the gaps, repeat the process with a 500bp offset and choose 
the reverse complement primers that bind in the middle of the sequence. This will also 
increase the fidelity of the sequence data (see Figure 2). 
4. After choosing the primers, order them from an oligo synthesis company. If you have 
multiple primers, a 96-well plate format may be convenient. Resuspend them in either 
nanopure water or 10mM Tris-HCl, pH=8.5 at 100µM, vortex, and centrifuge briefly. 
5. Keep all PCR materials on ice and set up your PCR reaction in a 96-well plate according 
to Table 1. Reserve one well for a negative control PCR (no template, choose any primer 
pair) to check for contamination. Run PCR using a thermocycler according to Table 2. If 
the sequencing region is longer than 1kb, it is possible to make a long PCR product and 
then submit multiple sequencing primers for a single template (up to 5kb) (see Note 11). 
For higher fidelity, especially at longer sequencing templates (>5kb) or difficult 
templates (high GC content), use the QIAGEN® LongRange PCR kit according to Table 
3 and Table 4. 
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6. Check the concentration of the PCR products using a nanodrop (see 3.1.3). Check the 
size of the PCR product on a 1% TAE agarose gel. 
6.1. Melt 1X TAE with 1% agarose gel in a standard microwave. Add 25mL with 2 drops 
of ethidium bromide to a 8.5x10 cm gel casting tray in a gel casting tray holder with 
either an 8 or 15 sample comb (see Note 12). For more samples, use a 17x10 gel 
casting tray with a 26 sample comb. In this case, use 50mL of 1% TAE agarose gel 
with a few drops of ethidium bromide. Allow 30 minutes for the gel to solidify. 
6.2. Remove the comb and the gel casting tray. Place the gel casting tray into the gel box. 
Add 1X TAE until the surface of the gel is covered evenly. 
6.3. Mix standard and samples according to Table 5. Mix the standard and load into the 
first well; perform the same with each sample. Set the voltage to 100, put the top on, 
and click “run” (see Note 13). Wait 45 minutes - 1 hour for the dye to reach the 
bottom. Turn the system off when finished. 
6.4. Use the UV camera to visualize the PCR products. Match the standard with the PCR 
product to determine the approximate size (see Note 14). 
7.  If the PCR worked as expected, submit samples for sequencing by a core facility or 
company. The sample may need to be purified (use a standard PCR Purification Kit 
protocol) before submission (check the submission requirements). Use the sequencing 
primers as described in Figure 2 (see Note 15). The sequencing data is returned as .ab1 
trace files and .seq files. One can view the .seq files in any text editor program. More 
advanced analysis requires the use of .ab1 trace files and DNA sequence finishing 
software. 
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8. In CodonCode Aligner (or any sequence finishing software), load the forward and reverse 
sequence of the samples. The first 20 bases and the last few bases (depends on the 
sequence length) have low quality scores. Highlight the samples and choose “clip ends” 
using the default parameters. Highlight the overlapping samples and assemble them into 
contigs (see Figure 3). The consensus sequence is shown at the bottom, where the base 
with the highest quality score is chosen. Here one can manually edit the sequence and call 
individual bases that are difficult. If there are discrepancies, open the trace files again to 
determine which is correct (see Note 16). 
9. Use the BLASTn alignment tool (choose “Align two or more sequences” option) to align 
the consensus sequence to the parent strain and wildtype sequence. Sequences that are not 
matching or are unknown can be found using the NCBI nucleotide BLAST database. 
Notes 
1. The methods described here are developed in our lab, unless it is a published protocol 
from Illumina, INC. or commercial kit protocols. The steps using commercial kits are the 
published protocols of the kit manufacturer, where special deviations are in italics. 
Harvesting cells at 4°C, 4,000rpm prevents lysis and increases DNA yields. Do not 
overload the DNA column. Overloading the column causes blockage of the membrane 
and decrease yields. To obtain the maximum cell count per DNA column, first obtain a 
correlation of OD (we use 550 nm for E. coli) to C cells/mL (outside the scope of this 
protocol). Next, use to calculate the amount of cells you need: 
!	#	$%&'())*'	'())* +,- #	$%	+,	 = /	0122% (1) 
For example, if C = 1.69 x 108, we have !	#	$%&'())*$.45	'())* +,- 	#	$%	+,	 = 1.18	0122%. Therefore, 10 
mL, OD550 1.18 is required to obtain 2 x 109 cells. 
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2. The ethanol, sample and Buffer AL need to be mixed immediately and thoroughly by 
vortexing. Otherwise local precipitation may occur in the sample, which will decrease 
yields. 
3. Buffer AL and Buffer AW1 are not compatible with bleach and may form decomposition 
products. 
4. The column must be dried before eluting the DNA. Residual ethanol will decrease yields. 
5. Subsequent elution steps will increase DNA yields, but decrease concentration. Do not 
elute more than 200 µl into a single 1.5 ml microfuge tube. 
6. The insert sizes are less than 800 bp. We typically use 400-500 bp. 
7. Due to possible polar effects from upstream mutations, the researcher may want to 
include the complete sequence from the promoter to the stop codon of the gene of 
interest. The sequencing length may be prohibitive and costly, so it is up to the researcher 
to include the upstream sequences along with the gene of interest. This is especially true 
if there are many genes in between the annotated promoter sequence and the gene of 
interest. 
8. For example, the E. coli gene carB is 3,222 bp; therefore, round up to 4,000 bp by using 
this formula: 4,000-3,222=778/2=389 bp. Add 389 bp upstream and downstream of the 
carB gene. The total sequence is therefore 4,000 bp with the carB gene in the middle. 
This is enough to include a sequencing primer region and the promoter sequence 42bp 
from the translational start. 
9. The limit of good quality Sanger sequence reads is about 1,000 bp. The Primer3 program 
chooses optimal primers and performs in silico PCR to obtain PCR products in the 
desired range. This ensures that each primer has approximately the same length and 
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melting temperature. It is good to also select alternate primers in case the primers weakly 
bind to the template. If the region is heavily mutated, it may be difficult choosing the 
correct primers. 
10. NCRs may include long blocks of A-T rich sequences and therefore optimal primers may 
not be available. In this case, adjust the target sequence, so that the mutated region is 
closer to either the 5’ end or 3’ end. This way one can obtain optimal primers that can be 
used for sequencing this region. 
11. QIAGEN® Taq DNA Polymerase is for general applications. For longer PCR products, 
the probability for incorporation of the incorrect base increases (false SNP); therefore, the 
use of a higher fidelity enzyme (i.e., QIAGEN® LongRange PCR kit) is recommended. 
Higher fidelity PCR enzymes are recommended for SNP identification and resequencing 
applications. It depends on the researcher which option is best. For extremely long PCR 
(10kb-40kb), the researcher is referred to the QIAGEN® LongRange PCR Handbook for 
an alternate PCR protocol. 
12. Ethidium bromide is toxic and mutagenic. Always wear proper protection equipment. 
13. Make sure that the diode colors match (black with black and red with red) and that the 
black one is at the top. This ensures that the DNA samples will run through the gel in the 
correct direction. Also the dye should not run off the gel, otherwise one may lose the 
samples. 
14. If DNA bands are not visible, soak the gel for 1 hour in 1X TAE with ethidium bromide. 
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15. Use the following formula to calculate the number of sequencing reactions: #Quality	Sequences = 	 FG$%%% ∗ 2 − 1 (2)  
16. Common mismatches occur when the local sequence contains blocks of the same base 
(i.e., A block of 6 A’s in a row), or the ends are overlapping with one sample containing 
poor quality bases. This step may not be necessary as the consensus sequence is called 
according to quality. If SNPs or indels are discovered, this step becomes much more 
difficult, especially if there are duplication events. 
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Tables 
Table 1. A Typical 20 µL PCR Reaction 
Material Stock Concentration Amount to add Final concentration 
Nuclease-free water - Variable - 
Primer A 100 µM 0.1 µL 500 nM 
Primer B 100 µM 0.1 µL 500 nM 
Template Variable Variable 50-500 ng 
2X QIAGEN® Taq 
PCR Master Mix 
2X 10 µL 1X or 2.5U Taq + 200 
µM dNTP 
 
Table 2. Typical PCR Reaction Conditions 
Step Time Temperature Comments 
1. Denaturation 4 min 94°C Denaturation of template and primer-
dimers 
2. Denaturation cycle 0.5 min 94°C Or 5°C below the lowest primer 
melting temperature 
3. Annealing cycle 0.5 min 55°C  
4. Extension cycle 1 min/kb 72°C  
5. Repeat steps 2-4   Repeat 30 times 
6. Final extension 10 min 72°C  
7. End infinite 5°C  
 
Table 3. 20 µL QIAGEN® LongRange PCR Kit (up to 10kb) Setup 
Material Stock Concentration Amount to add Final concentration 
Nuclease-free water - Variable - 
Primer A 10 µM (diluted 10 fold) 0.8 µL 400 nM 
Primer B 10 µM (diluted 10 fold) 0.8 µL 400 nM 
Template Variable (diluted 10 
fold) 
Variable 0.1-10 ng 
dNTP mix 10 mM of each base 1 µL 500 µM of each base 
QIAGEN® LongRange 
PCR buffer 
10X 2 µL 1X or 2.5U Mg2+ 
QIAGEN® LongRange 
PCR enzym Mix 
100U (total enzyme 
mix) 
0.16 µL 0.8U 
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Table 4. QIAGEN® LongRange PCR Reaction Conditions 
Step Time Temperature Comments 
1. Denaturation 3 min 93°C Denaturation of template and primer-
dimers 
2. Denaturation cycle 15 s 93°C Or 5°C below the lowest primer 
melting temperature 
3. Annealing cycle 0.5 min 62°C  
4. Extension cycle 1 min/kb 68°C  
5. Repeat steps 2-4   Repeat 35 times 
6. End infinite 4°C  
 
Table 5. Recipe for Mixing Standard and Samples 
Standard Samples 
Standard 1 µL PCR product 8 µL 
Dye 2 µL Dye 2 µL 
Nuclease-free water 7 µL Nuclease-free water - 
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Figures 
Figure 1. Illumina sample preparation Protocol 
Illumina sample preparation protocol, adapted from the Illumina guide Preparing Samples 
for Sequencing Genomic DNA. See the Illumina guidebooks for their detailed protocols. 
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Figure 2. Schematic for designing sequencing Primers for long sequencing regions 
The average quality score is plotted for each individual base along the template. A quality 
score of 20 or greater is considered acceptable. Choose the forward primer binding to the 
lagging strand to cover the general area (top). To fill the gaps, use the reverse primer 
binding to the leading strand, with a 500 bp offset. In this example, the forward sequencing 
primers will bind to bases 1, 1000, 2000, & 3,000. The reverse sequencing primer will bind 
to bases 3,500, 2,500, & 1,500. 
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Figure 3. Contig assembly in CodonCode Aligner 
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APPENDIX B.    E. COLI VARIANT ANALYSIS (EVA) USER GUIDE 
Software Requirements 
EVA requires Java to be installed as well as access to a copy of the RegulonDB 
database and the EVA supplementary database. Additionally, Provean and Vienna RNA 
packages must be installed for various analyses to be performed. Networks generated by 
EVA can be viewed using various visualization software. EVA provides a custom style for 
use with Cytoscape. 
Commands 
 
EVA: E. coli Variant Analysis 1.0 
Annotate, analyze, and prioritize E. coli mutations in comma separated value (.csv) files, text 
(.txt) files, and GenomeDiff (.gd) files. 
 
Usage: java -jar eva.jar -d derivative1.gd [-d derivative2.gd...] [-p parent1.gd...] [options] 
java -jar eva.jar -r N [options] 
 
Options: 
File 
-d, --derivative <file_path> path to CSV file containing sequence variations in derivative 
(i.e., evolved) strain 
-p, --parent <file_path> Path to CSV file containing sequence variations in parent (i.e., 
ancestral) strain 
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-r, --random <integer> Run EVA for N random mutations instead of importing from 
file(s) 
-o, --output <path>  Path to desired project output directory (DEFAULT = output) 
 
Annotation 
--exact    Annotate all features in large mutations that regulate 1+ 
features outside the mutation (DEFAULT = ignore non-coding features in large mutations) 
--large_mutation <integer> The size (in bp) for which to consider a mutation "large" 
(DEFAULT = 1000) 
 
Analysis 
--noRNA    Do not predict optimal secondary structures or 
minimum free energy for RNA features 
--noAA    Do not run PROVEAN analysis on variant amino acid 
sequences 
--provean_threshold <double> Cutoff PROVEAN score for assigning HIGH priority. 
Scores less than or equal to this value are predicted to be damaging. (DEFAULT = -2.5) 
--num_threads <integer>  Number of threads to use in BLAST search (DEFAULT 
= 1) 
--maxRNA <integer>   Maximum length of RNA to submit for RNA analysis. 
(DEFAULT = 1000) 
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--deltaMFE <double>   Cutoff change in MFE for assigning HIGH priority, in 
standard deviations. Final cutoff is calculated per RNA sequence. Cannot be used with --
edit_distance. (DEFAULT = 1) 
--edit_distance <integer>  Use Levenshtein distance between predicted optimal 
structures instead of free energy calculations. Cannot be used with --deltaMFE_threshold. 
Network 
--full_network    Construct network with all features and links 
(DEFAULT = abbreviated network that consolidates select interactions) 
--regulatory_steps <integer>  Number of regulatory steps to incorporate when 
building network (DEFAULT = 1) 
--derivative_networks   In addition to a network formed from all samples, 
construct a network for each derivative from mutations that are not common to that 
derivative and parent sample(s) 
 
Help 
-h, --help    Print help and exit 
 
Multiple parent and derivative files may be submitted at once. At least one derivative file is 
required to run EVA. 
 
CSV files must contain one mutation per line: 
POS,REF,ALT 
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where POS is the position on the genome, REF is the reference DNA sequence, and ALT is 
the alternate DNA sequence. 
 
Output files for mutation analysis and network generation can be found in the specified 
output directory. 
 
EVA.out is a tab delimited text file containing the results of the EVA analysis. Additional 
files for network and PROVEAN analysis are located in their respective directories. 
 
Networks are formed from seed nodes representing features that correspond to mutations that 
are not present in all samples (if more than one sample is imported). 
 
Additional configuration options can be found in the config.properties file. 
 
Configuration 
Config.properties file: 
# The name of the installed RegulonDB database 
RegulonDB_database=regulondb94 
 
# The name of the installed EVA database (e.g., eva) 
EVA_database=eva 
 
# The server to connect to for database access (e.g., localhost) 
server=localhost 
 
# The port number 
port=8889 
 
# The username to access the databases 
username=root 
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# The password to access the databases 
password=root 
 
# Absolute path to provean.sh from PROVEAN installation (e.g., 
/usr/local/bin/provean.sh) 
PROVEAN=/usr/local/bin/provean.sh 
 
# Path to compiled PROVEAN library (available with EVA in ProveanLibrary 
directory) 
PROVEAN_library=/path/to/ProveanLibrary 
 
# Directory containing Vienna RNA executables (e.g., /usr/local/bin/) 
ViennaRNA=/usr/local/bin/ 
 
# Output fields. * denotes fields automatically included in output 
regardless of configuration. 
# * POS   Position in the reference genome 
# * REF   Reference sequence (DNA) 
# * ALT   Alternate sequence (DNA) 
#  VARIATION  Type of sequence variation 
#  SPAN   How the sequence variation corresponds to an 
annotation 
#  GENE_MUTATION Type of gene mutation 
# * FEATURE_ID  Feature identifier in RegulonDB or EcoCyc database 
# * FEATURE_TYPE Type of feature corresponding to the mutation 
# * FEATURE_NAME Name of Feature 
#  BNUM   B-number (only applicable for genes) 
#  STRAND  Feature strand (+ corresponds to forward strand, - 
corresponds to reverse strand) 
#  FEATURE_LEFT Leftmost position of feature 
#  FEATURE_RIGHT Rightmost position of feature 
#  FEATURE_REF  Feature reference sequence (DNA) 
#  FEATURE_ALT  Feature alternate sequence (DNA) 
#  FEATURE_AA_REF Feature reference sequence (AA, only applicable 
for genes) 
#  FEATURE_AA_ALT Feature alternate sequence (AA, only applicable 
for genes) 
#  SEQ_EDIT_DIST The Levenshtein distance between the reference and 
alternate feature sequence 
#  STRUCTURE_DIST The edit distance between reference and alternate 
feature predicted structures (only applicable for RNA features) 
#  HGVS   Description of mutation following Human Genome 
Variant Society nomenclature, used for PROVEAN analysis (only applicable 
for protein-coding gene features) 
#  PROVEAN  PROVEAN score (only applicable for protein-coding 
gene features) 
#  RNA_THRESHOLD Delta MFE threshold for assigning high priority 
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#  RNA_MFE_REF  Predicted MFE for reference sequence (only 
applicable for RNA features) 
#  RNA_MFE_ALT  Predicted MFE for alternate sequence (only 
applicable for RNA features) 
#  RNA_STRUCT_REF Predicted secondary structure for reference 
sequence (only applicable for RNA features) 
#  RNA_STRUCT_ALT Predicted secondary structure for alternate 
sequence (only applicable for RNA features) 
#  SIGMA70_REF  Sigma70 predicted MFE for reference sequence (only 
applicable for promoter features associated with sigma 70) 
#  SIGMA70_ALT  Sigma70 predicted MFE for reference sequence (only 
applicable for promoter features associated with sigma 70) 
# * PRIORITY  Priority assigned to mutation (UNASSIGNED, LOW, 
HIGH) 
# * COMMENT  EVA comments and errors running analysis 
 
# User-specified fields to include in output file. 
fields=VARIATION,\ 
SPAN,\ 
GENE_MUTATION,\ 
BNUM,\ 
STRAND,\ 
FEATURE_LEFT,\ 
FEATURE_RIGHT,\ 
FEATURE_REF,\ 
FEATURE_ALT,\ 
FEATURE_AA_REF,\ 
FEATURE_AA_ALT,\ 
SEQ_EDIT_DIST,\ 
STRUCTURE_DIST,\ 
HGVS,\ 
PROVEAN,\ 
RNA_THRESHOLD,\ 
RNA_MFE_REF,\ 
RNA_MFE_ALT,\ 
RNA_STRUCT_REF,\ 
RNA_STRUCT_ALT,\ 
SIGMA70_REF,\ 
SIGMA70_ALT 
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Hierarchy for all packages 
Class Hierarchies 
• java.lang.Object 
o annotation.AbstractAnnotation<T> (implements java.lang.Comparable<T>) 
§ annotation.impl.Annotation 
§ annotation.impl.GeneAnnotation 
§ annotation.impl.PromoterAnnotation 
§ annotation.impl.RNAAnnotation 
§ annotation.impl.Unannotated 
o dao.AbstractDatabaseDAO 
§ dao.impl.EvaDBDAO 
§ dao.impl.RegulonDBDAO 
o feature.AbstractFeature 
§ feature.AbstractGenomicFeature 
• feature.AbstractPromoterFeature 
o feature.impl.Box10 
o feature.impl.Box35 
• feature.impl.AttenuatorTerminator 
• feature.impl.Gene 
• feature.impl.Operon 
• feature.impl.Rfam 
• feature.impl.ShineDalgarno 
• feature.impl.SRNAbs 
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• feature.impl.Terminator 
• feature.impl.Tfbs 
§ feature.impl.Attenuator 
§ feature.impl.Pathway 
§ feature.impl.Product 
§ feature.impl.Reaction 
§ feature.impl.TranscriptionFactor 
§ feature.impl.TranscriptionUnit 
o dao.AbstractFeatureDAO 
§ dao.impl.AttenuatorDAO (implements dao.FeatureDAO) 
§ dao.impl.AttenuatorTerminatorDAO (implements dao.GenomicFeatureDAO) 
§ dao.impl.Box10DAO (implements dao.GenomicFeatureDAO) 
§ dao.impl.Box35DAO (implements dao.GenomicFeatureDAO) 
§ dao.impl.GeneDAO (implements dao.GenomicFeatureDAO) 
§ dao.impl.OperonDAO (implements dao.GenomicFeatureDAO) 
§ dao.impl.PathwayDAO (implements dao.FeatureDAO) 
§ dao.impl.ProductDAO (implements dao.FeatureDAO) 
§ dao.impl.ReactionDAO (implements dao.FeatureDAO) 
§ dao.impl.RfamDAO (implements dao.GenomicFeatureDAO) 
§ dao.impl.ShineDalgarnoDAO (implements dao.GenomicFeatureDAO) 
§ dao.impl.SRNAbsDAO (implements dao.GenomicFeatureDAO) 
§ dao.impl.TerminatorDAO (implements dao.GenomicFeatureDAO) 
§ dao.impl.TfbsDAO (implements dao.GenomicFeatureDAO) 
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§ dao.impl.TranscriptionFactorDAO (implements dao.FeatureDAO) 
§ dao.impl.TranscriptionUnitDAO (implements dao.FeatureDAO) 
o network.AbstractNetwork 
o result.AbstractResult 
§ result.GeneResult 
§ result.GenericResult 
§ result.PromoterResult 
§ result.RNAResult 
§ result.UnannotatedResult 
o analysis.AnalysisStrategyFactory 
o annotation.AnnotationFactory 
o analysis.BindingSiteStrategy (implements analysis.AnalysisStrategy<T>) 
o sequence.Codon 
o core.Consts 
o network.Edge 
o core.EVA 
o util.fileImport.FastaReader 
o dao.FeatureDAOFactory 
o feature.FeatureLink 
o java.util.logging.Formatter 
§ util.ConsoleFormatter 
o analysis.GenericStrategy (implements analysis.AnalysisStrategy<T>) 
o analysis.GeneStrategy (implements analysis.AnalysisStrategy<T>) 
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o annotation.HGVS 
o feature.Interaction 
o genome.Interval 
o genome.IntervalComparator (implements java.util.Comparator<T>) 
o jdbc.impl.JdbcManagerImpl (implements jdbc.JdbcManager) 
o util.Kmer 
o util.LevenshteinAlignment 
o genome.MergeIntervals 
o mutation.Mutation (implements java.lang.Comparable<T>) 
o mutation.MutationComparator (implements java.util.Comparator<T>) 
o util.fileImport.MutationImporter 
o network.Network 
§ network.Branch 
o network.NetworkBuilder 
o network.Node 
§ network.RootNode 
o util.fileImport.ParseCSV 
o util.fileImport.ParseGD 
o util.fileImport.ParseProvean 
o util.fileImport.ParseVCF 
o core.Project 
o analysis.PromoterStrategy (implements analysis.AnalysisStrategy<T>) 
o util.scripts.ProveanResult 
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o util.RandomMutation 
o feature.Regulation 
o util.ResultFormat 
o util.scripts.RNAfoldResult 
o analysis.RNAStrategy (implements analysis.AnalysisStrategy<T>) 
o core.RunEVA 
o util.scripts.RunProvean 
o util.scripts.RunVienna 
o sequence.Sequence (implements java.lang.Comparable<T>) 
§ sequence.AA 
§ sequence.DNA 
§ sequence.RNA 
o network.ShortestPath 
o util.Statistics 
o annotation.TestHGVS 
o java.lang.Throwable (implements java.io.Serializable) 
§ java.lang.Exception 
• analysis.AnalysisException 
• core.InitializationException 
• util.fileImport.MutationImportException 
• java.lang.RuntimeException 
o annotation.AnnotationException 
o dao.exception.DataAccessException 
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§ dao.exception.DataAccessConnectionFailureException 
§ dao.exception.DataAccessSQLException 
o feature.FeatureException 
o mutation.MutationException 
o sequence.SequenceException 
• sequence.TranslationException 
o util.VariantGenerator 
Interface Hierarchy 
• analysis.AnalysisStrategy<T> 
• dao.FeatureDAO 
o dao.GenomicFeatureDAO 
• jdbc.JdbcManager 
• jdbc.RowMapper<T> 
 
Enum Hierarchy 
• java.lang.Object 
o java.lang.Enum<E> (implements java.lang.Comparable<T>, java.io.Serializable) 
o util.ResultFormat.Columns 
o feature.impl.Terminator.TerminatorClass 
o feature.impl.Attenuator.AttenuatorType 
o feature.impl.Gene.GeneType 
o feature.impl.AttenuatorTerminator.AttenuatorTerminatorType 
o feature.impl.Product.ProductType 
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o feature.impl.Pathway.PathwayType 
o core.Priority 
o core.Consts.Database 
o core.Consts.Genome 
o core.Consts.RegulonDB 
o sequence.Strand 
o annotation.Span 
o annotation.HGVS.HGVSType 
o annotation.GeneMutationType 
o annotation.TestHGVS.HGVSpattern 
o network.Distance 
o mutation.Mutation.Variation 
o feature.Mechanism 
o feature.Interaction.InteractionType 
o feature.FeatureType 
o feature.AbstractPromoterFeature.SigmaFactor 
 
